Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3023199	pf-leuk	e6/l (e6/l)	3083	4375	0.00%
3023199	pf-leuk	— (—)	1352	1884	100.00%	Distribution not available
3023199	pf-leuk	e9/l (e6/l)	47	49	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Later onset COPD, excluding more controls

375

245

12.25

321.72

1.5

1.2

2255.99

1221.69

e6/l

1.68

282

157

Non-ischemic cardiomyopathy

688

1042

5.52

320.23

1.5

1.4

3432.77

3467.30

e6/l

0.01

487

760

Abnormal findings on diagnostic imaging of lung

965

2421

3.93

317.16

1.6

1.4

3214.48

2884.15

e6/l

0.18

753

1729

Bacterial Sepsis

925

1958

4.15

316.53

1.6

1.4

4177.41

2805.43

e6/l

0.56

679

1447

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1104

2830

3.57

310.96

1.6

1.4

3047.92

3050.12

e6/l

0.00

861

2016

ILD differential diagnosis

801

399

10.19

307.65

1.5

1.1

2431.64

2117.70

e6/l

0.29

583

267

Malignant neoplasm of bronchus and lung, including Hilmo

650

782

7.36

307.65

1.4

1.5

2699.23

2686.61

e6/l

0.01

472

582

Bacterial infection, other or unspecified

1150

2083

4.80

307.65

1.6

1.4

3817.41

2670.29

e6/l

0.62

839

1529

Other medical care

1040

1794

5.40

307.65

1.5

1.4

2025.12

2940.67

e6/l

1.10

770

1307

Non-small cell lung cancer, including Hilmo

515

624

8.30

307.65

1.4

1.5

2475.69

2883.05

e6/l

0.23

375

463

Any death

1458

1511

7.20

307.65

1.5

1.4

3058.18

3275.29

e6/l

0.10

1093

1050

Renal tubulo-interstitial diseases

1248

2673

3.54

307.65

1.6

1.4

2642.25

3408.91

e6/l

0.56

880

1972

Renal failure

999

2286

3.99

307.65

1.6

1.4

1978.39

3197.82

e6/l

1.07

710

1691

1488

1651

5.57

307.65

1.5

1.4

4570.51

2657.26

e6/l

1.33

1084

1176

Persons encountering health services for specific procedures and health care

1339

2300

3.54

307.65

1.5

1.4

3675.57

3564.46

e6/l

0.04

960

1670

All-cause Heart Failure

1336

1751

5.59

307.65

1.6

1.4

2632.14

3405.09

e6/l

0.40

968

1290

Bacterial infection, other or unspecified

1095

2056

4.76

307.65

1.6

1.4

3748.22

2707.39

e6/l

0.52

803

1502

Pneumonia, organism unspecified

1575

1898

5.95

307.65

1.5

1.4

4479.70

2874.64

e6/l

1.06

1151

1365

COPD differential diagnosis

801

399

10.19

307.65

1.5

1.1

2431.64

2117.70

e6/l

0.29

583

267

Oxycodone

824

1605

4.80

307.65

1.5

1.4

2069.26

2741.29

e6/l

0.73

620

1163

Excluding asthma or asthma-COPD overlap

807

398

10.29

307.65

1.5

1.1

2433.50

2127.68

e6/l

0.28

586

267

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1654

2008

5.74

307.65

1.5

1.4

4421.25

2853.89

e6/l

1.09

1201

1446

Asthma, excluding more controls

522

191

14.39

307.65

1.5

1.1

2569.23

3342.55

e6/l

0.47

381

139

Suppurative and necrotic conditions of lower respiratory tract

435

245

21.88

307.65

1.6

1.4

16536.41

1463.96

e6/l

4.56

303

180

Influenza and pneumonia

1638

1921

5.53

307.65

1.5

1.4

4437.80

2933.33

e6/l

1.00

1189

1383

COPD (mode)

508

303

13.57

307.65

1.4

1.2

3080.73

1536.93

e6/l

1.38

390

195

Pleural effusion

1896

425

61.28

307.65

1.7

1.2

2582.58

3122.47

e6/l

0.29

1428

280

Asthma (only as main-diagnosis), excluding more controls

454

191

13.71

307.65

1.5

1.1

2546.99

3342.55

e6/l

0.47

342

139

Heart failure and antihypertensive medication

553

466

8.06

307.65

1.6

1.4

3703.00

4433.23

e6/l

0.15

407

344

Pneumonias (Asthma/COPD co-morbidities)

1658

1977

5.75

307.65

1.5

1.4

4421.83

2877.88

e6/l

1.06

1201

1423

Heart failure, not strict

1392

1643

5.92

307.65

1.6

1.4

2734.31

4081.55

e6/l

0.80

1011

1203

Heart failure, strict

1372

1786

5.63

307.65

1.6

1.4

2574.22

3384.43

e6/l

0.45

997

1312

Asthma, unspecified (mode), excluding more controls

448

182

18.66

307.65

1.5

1.1

2747.50

3272.51

e6/l

0.25

329

132

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1488

1651

5.57

307.65

1.5

1.4

4570.51

2657.26

e6/l

1.33

1084

1176

Dyspnoea

1438

2716

3.99

307.65

1.6

1.4

3005.24

3222.77

e6/l

0.12

1096

1920

Heart failure,strict

1242

1316

6.93

307.65

1.6

1.4

2628.86

3528.82

e6/l

0.44

904

967

Pyothorax

399

204

25.42

307.65

1.7

1.5

16882.55

1475.73

e6/l

4.19

275

145

Other pleural conditions

1087

275

52.20

307.65

1.8

1.2

2047.50

1825.38

e6/l

0.17

889

182

All pneumoniae

1662

1971

5.76

307.65

1.5

1.4

4408.42

2886.70

e6/l

1.04

1204

1420

Other bacterial diseases

1437

2435

4.04

307.65

1.5

1.4

3897.21

2985.42

e6/l

0.51

1029

1768

Malignant neoplasm of respiratory system and intrathoracic organs

759

767

8.83

307.65

1.5

2492.74

2719.35

e6/l

0.15

570

571

Other bacterial diseases

1405

2305

3.93

307.65

1.6

1.4

4062.53

2965.67

e6/l

0.63

1010

1682

Asthma, unspecified (mode)

472

383

9.40

307.65

1.5

1.1

3390.10

2065.26

e6/l

0.91

345

257

Malignant neoplasm of bronchus and lung

585

687

7.50

307.65

1.4

1.5

2595.54

2854.77

e6/l

0.15

432

510

Other diseases of pleura

2587

1133

22.44

307.65

1.6

1.2

2781.48

4421.42

e6/l

0.75

1989

745

Other pulmonary diagnosis

819

398

10.45

307.65

1.5

1.1

2384.81

2127.68

e6/l

0.23

595

267

Lung cancer and mesothelioma

776

211

34.21

307.65

1.5

1.2

2540.25

1111.54

e6/l

5.27

579

134

Non-small cell lung cancer

376

430

9.36

301.25

1.4

1.5

2388.47

3107.08

e6/l

0.33

275

314

Diseases of the respiratory system

593

393

7.65

294.19

1.5

1.2

2325.01

2024.14

e6/l

0.26

433

269

Bacterial pneumoniae

692

1279

4.89

294.10

1.5

1.4

4226.98

2263.61

e6/l

0.74

513

921

All chronic kidney diseases

944

2068

3.82

285.72

1.6

1.4

1690.63

3438.71

e6/l

1.70

674

1535

Bacterial pneumonia, not elsewhere classified

669

1237

4.88

283.79

1.5

1.4

4304.63

2165.35

e6/l

0.79

496

894

Non-small cell lung cancer, adenocarcinoma

269

215

13.95

280.31

1.5

2694.08

1525.34

e6/l

1.57

199

153

Implicit bacterial Sepsis

864

1930

3.97

279.81

1.6

1.4

4314.91

2777.68

e6/l

0.60

637

1426

Implicit bacterial Sepsis

827

1849

4.08

279.57

1.6

1.4

4405.09

2799.32

e6/l

0.61

619

1369

Septicaemia

786

1815

4.16

277.76

1.6

1.4

4396.29

2694.05

e6/l

0.61

578

1332

Asthma

555

396

7.41

276.89

1.5

1.1

2483.69

2121.73

e6/l

0.33

408

266

Implicit Sepsis

1086

2451

3.40

271.80

1.5

1.4

3835.53

3010.15

e6/l

0.35

796

1792

Heart failure and bmi 25plus

656

871

5.25

270.88

1.6

1.4

3170.90

3749.16

e6/l

0.14

478

656

Heart failure and coronary heart disease

920

1730

3.89

270.35

1.6

1.5

1703.45

3599.67

e6/l

1.62

670

1271

Explicit Sepsis

800

1907

4.02

269.84

1.6

1.4

4356.98

2792.26

e6/l

0.56

586

1408

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

173

36.18

263.70

1.9

1.5

1943.39

1981.31

e6/l

0.02

136

Malignant neoplasm of heart, mediastinum and pleura

155

55.52

261.80

2.0

1.3

1842.34

2422.93

e6/l

0.38

126

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1256

2871

3.06

259.20

1.5

3175.95

3208.10

e6/l

0.01

910

2089

Abnormalities of breathing

1066

1783

3.52

258.04

1.6

1.4

2551.20

3348.40

e6/l

0.58

790

1248

Dialysis, with operation codes

362

507

7.58

246.51

1.7

1.4

1561.91

2185.56

e6/l

0.77

274

376

Asthma (only as main-diagnosis)

482

396

7.11

246.38

1.5

1.1

3045.91

2121.73

e6/l

0.62

359

266

Mesothelioma, including Hilmo

152

45.97

244.36

2.1

1.3

1657.06

2442.40

e6/l

0.63

123

Other heart diseases, wide

901

1495

3.73

241.30

1.5

1.4

2564.90

3877.55

e6/l

1.10

648

1095

All kidney diseases

1167

2640

3.06

240.57

1.5

1.4

2690.46

3793.79

e6/l

0.85

818

1941

Implicit Sepsis

1071

2494

3.19

240.28

1.5

1.4

3834.37

3094.22

e6/l

0.30

779

1818

Asthma (mode)

504

399

6.82

239.08

1.5

1.1

2846.77

2117.70

e6/l

0.68

380

267

Other septicaemia

693

1700

4.03

236.26

1.6

1.4

4714.55

2689.12

e6/l

0.67

516

1248

Mesothelioma

140

59.27

235.41

2.1

1.3

1693.77

2509.39

e6/l

0.54

115

Other heart diseases

480

507

6.27

234.45

1.5

1.3

2528.62

4155.73

e6/l

0.98

346

374

Nephropathy related operations

346

518

7.09

221.72

1.7

1.4

1236.39

2502.07

e6/l

2.72

259

384

Acute renal failure

515

1113

4.82

221.65

1.6

1.4

2528.42

2538.45

e6/l

0.00

370

815

Chronic kidney disease

671

1729

3.94

221.48

1.6

1.4

1779.58

2589.02

e6/l

0.59

485

1275

Anaemias

224

20.62

218.22

1.6

1.3

4865.73

5033.05

e6/l

0.02

158

Early onset COPD, excluding more controls

224

199

11.48

214.91

1.4

1.2

5391.70

2264.87

e6/l

0.84

168

126

Other diseases of pericardium

175

106

18.17

212.02

1.6

1.2

1678.07

3094.44

e6/l

1.30

134

Malignant neoplasm of mesothelium and soft tissue

181

121

16.83

209.10

2.0

1.5

1534.39

1931.46

e6/l

0.50

140

Non-small cell lung cancer, adenocarcinoma, helper endpoint

269

330

9.04

207.17

1.5

1.4

2694.08

1979.67

e6/l

0.71

199

230

Valvular heart disease excluding rheumatic fever

634

1128

4.14

205.85

1.6

1.4

2594.99

3348.83

e6/l

0.44

471

838

COPD/asthma/ILD related infections

1038

1651

3.18

205.35

1.6

1.4

3340.08

2657.26

e6/l

0.39

770

1176

COPD/asthma related infections

1038

1651

3.18

205.35

1.6

1.4

3340.08

2657.26

e6/l

0.39

770

1176

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

444

890

5.09

204.54

1.4

1.5

2099.95

2696.40

e6/l

0.51

324

648

Non-rheumatic valve diseases

631

1125

4.12

204.10

1.6

1.4

2530.36

3357.80

e6/l

0.49

469

835

Condition for Implicit Sepsis (Organ dysfunction codes)

1024

2473

2.96

201.63

1.5

1.4

3879.26

3180.73

e6/l

0.26

746

1807

Liquid cancers, helper endpoint

568

1207

4.20

199.79

1.5

2178.04

3848.00

e6/l

1.09

423

895

Malignant neoplasm

883

1594

3.32

197.70

1.4

1.5

2425.23

4406.58

e6/l

1.65

631

1164

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

364

645

5.86

196.11

1.4

1.5

1741.99

2573.90

e6/l

0.85

275

472

Atrial fibrillation and flutter

389

415

6.19

186.97

1.6

1.3

1385.48

3936.07

e6/l

5.08

283

307

Malignant neoplasm, wide definition for exclusion

873

1613

3.21

185.45

1.5

2303.75

4394.51

e6/l

1.86

629

1176

Condition for Implicit Sepsis (Organ dysfunction codes)

985

2390

2.87

183.23

1.5

1.4

4203.85

3166.67

e6/l

0.41

718

1750

Solid cancers, helper endpoint

848

1581

3.20

180.02

1.4

1.5

2114.24

4256.90

e6/l

2.00

602

1157

Fever of other and unknown origin

723

2011

3.25

177.19

1.5

1.4

4321.87

2888.24

e6/l

0.44

536

1454

Cardiomyopathy

318

545

6.03

177.18

1.6

1.3

4174.95

3144.04

e6/l

0.13

217

402

Continuous positive airway pressure

309

414

6.45

172.89

1.5

1.4

2622.84

3512.36

e6/l

0.29

232

296

Care involving dialysis

215

250

9.13

171.34

1.7

1.4

1008.07

2029.25

e6/l

1.41

160

185

Bacterial pneumonia (organism specified)

726

2122

3.17

170.41

1.5

4050.93

2558.87

e6/l

0.53

541

1534

Any event in cancer register

880

1745

3.00

168.16

1.5

2847.57

4241.41

e6/l

0.89

632

1262

Any gastric operation

669

907

3.73

166.51

1.5

1.4

2410.30

5337.97

e6/l

1.80

490

627

GASTRO-related operations

669

907

3.73

166.51

1.5

1.4

2410.30

5337.97

e6/l

1.80

490

627

Non-invasive ventilation

306

471

5.91

161.78

1.5

1.4

3585.16

3327.39

e6/l

0.08

263

330

Erysipelas

832

2227

2.89

160.61

1.5

1.4

3364.30

2922.15

e6/l

0.14

601

1616

Pneumothorax

168

157

11.29

156.95

1.7

1.2

6222.10

1559.43

e6/l

0.89

128

101

Atrial fibrillation and flutter with reimbursement

335

364

5.97

154.37

1.5

1.3

1565.51

3823.53

e6/l

3.84

241

272

Ascites

219

317

7.35

145.03

1.6

1.4

1894.02

1805.09

e6/l

0.04

167

237

Diseases of arteries, arterioles and capillaries (FINNGEN)

300

352

6.01

144.79

1.5

1.3

1413.59

3844.80

e6/l

4.27

213

265

Aplastic and other anaemias

735

2477

2.82

141.70

1.5

3532.16

2568.64

e6/l

0.29

513

1821

First line medication for Crohn's disease

1091

2442

2.43

137.86

1.6

1.4

2451.94

3794.85

e6/l

1.38

801

1752

Cardiac arrhythmias

499

891

3.67

134.60

1.5

1.4

2296.12

4045.43

e6/l

1.30

365

654

Cardiomyopathy (excluding other)

229

387

6.12

129.67

1.5

1.3

5391.52

3387.89

e6/l

0.19

160

276

Erysipelas

665

2139

2.79

124.93

1.5

1.4

3550.56

2973.18

e6/l

0.16

484

1563

Cardiomyopathies, Primary/intrinsic

220

372

6.12

124.51

1.5

1.3

5582.96

3288.15

e6/l

0.22

154

265

Other anaemias

668

2365

2.74

122.28

1.5

3768.12

2578.12

e6/l

0.33

462

1737

Non-allergic asthma (mode), excluding more controls

113

13.96

122.19

1.6

1.1

3380.50

2108.73

e6/l

0.54

Other and unspecified anaemias

661

2350

2.73

120.69

1.5

3804.43

2588.98

e6/l

0.34

456

1727

Malaise and fatigue

628

1835

2.79

115.65

1.5

1.4

2918.33

2397.21

e6/l

0.27

449

1329

Extracorporeal dialysis

171

257

7.10

109.55

1.7

1.4

626.94

1727.22

e6/l

6.64

127

185

Respiratory insufficiency

114

103

11.35

108.11

1.6

1.2

3302.40

1085.07

e6/l

1.29

Hypertensive heart and/or renal disease

440

998

3.37

108.09

1.5

1.4

1544.64

4348.57

e6/l

1.64

313

728

Valvular operations

228

461

5.09

106.07

1.6

1.3

3924.81

2866.75

e6/l

0.24

165

341

Implicit viral Sepsis

407

1260

3.29

104.90

1.6

1.4

2415.21

2921.89

e6/l

0.19

287

927

Presence of cardiac and vascular implants and grafts

689

2035

2.56

104.67

1.5

1414.00

3308.51

e6/l

2.55

519

1465

Haemorrhage from respiratory passages

464

1386

3.07

103.92

1.5

1.4

2807.52

2673.68

e6/l

0.06

340

967

ILD medications: prednisolone, methylprednisolone, prednisone

1051

2730

2.17

103.75

1.6

1.4

2545.61

3532.10

e6/l

0.98

775

1976

Other disorders of fluid, electrolyte and acid-base balance

469

1509

3.02

103.08

1.6

1.4

5631.19

2347.37

e6/l

0.79

356

1099

Oral corticosteroids

1049

2920

2.15

102.62

1.6

1.4

2624.17

3496.16

e6/l

0.87

779

2113

Secondary uncertain malignant neoplasm

222

457

5.01

101.27

1.6

1.5

1613.10

2734.78

e6/l

1.06

175

337

Certain infectious and parasitic diseases

844

1784

2.39

100.23

1.6

1.4

2348.20

3393.03

e6/l

1.02

601

1298

Complications of surgical and medical care, not elsewhere classified

999

3225

2.14

100.16

1.5

3573.61

3043.32

e6/l

0.20

727

2340

COPD

661

2188

2.51

98.84

1.4

1.5

2969.49

2402.43

e6/l

0.39

488

1580

Diseases of arteries, arterioles and capillaries

842

2774

2.27

98.77

1.5

1787.24

3077.92

e6/l

1.90

593

2034

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

231

507

4.68

97.46

1.5

1788.82

2882.59

e6/l

1.01

176

367

Unspecified kidney failure

228

501

4.74

96.54

1.6

1.4

1412.24

1737.30

e6/l

0.33

157

372

Bleeding

910

2998

2.18

96.36

1.5

3893.08

2908.75

e6/l

0.39

665

2169

Tramadol

735

1876

2.43

96.11

1.6

1.4

2607.18

3249.60

e6/l

0.52

511

1357

Other chronic obstructive pulmonary disease

637

2132

2.51

94.87

1.4

1.5

2881.63

2356.91

e6/l

0.35

476

1544

AV-block

263

555

4.25

94.48

1.6

1.4

1184.09

2702.27

e6/l

2.83

195

415

Cardiovascular diseases (excluding rheumatic etc)

350

535

3.78

94.41

1.5

1.3

3268.90

4822.90

e6/l

0.84

240

393

Glomerular diseases

304

838

3.73

94.34

1.6

1.5

1272.23

2333.85

e6/l

1.96

226

603

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

901

2706

2.18

94.18

1.5

2648.37

3872.72

e6/l

1.06

673

1937

Implicit viral Sepsis

301

824

3.74

94.16

1.6

1.4

1383.10

2519.86

e6/l

2.20

215

613

Viral Sepsis

301

824

3.74

94.16

1.6

1.4

1383.10

2519.86

e6/l

2.20

215

613

Transplanted organ and tissue status

176

315

5.79

94.03

1.6

1.4

1885.06

2281.71

e6/l

0.19

124

223

Acute tubulo-interstitial nephritis

657

2351

2.44

93.98

1.5

1.4

3478.72

3200.39

e6/l

0.10

473

1758

Glomerular disorders in diseases classified elsewhere

231

524

4.58

93.88

1.6

1.4

1330.40

1889.21

e6/l

0.64

172

380

Conduction disorders

344

810

3.50

92.58

1.6

1.4

1176.02

2757.49

e6/l

4.99

249

605

Malignant neoplasm of ovary, including Hilmo

108

114

9.85

92.38

1.3

1.5

1497.30

2653.26

e6/l

0.52

Pericarditis

12.91

90.57

1.4

1.2

2057.23

2085.98

e6/l

0.02

ILD medications

1038

2737

2.07

90.48

1.6

1.4

2583.97

3531.94

e6/l

0.92

760

1979

Pulmonary heart disease, diseases of pulmonary circulation

477

1762

2.76

89.93

1.4

1.5

2008.95

2699.64

e6/l

0.77

344

1266

Inflammatory bowel disease treatment related agents

1057

2934

2.03

88.11

1.6

1.4

2533.02

3512.15

e6/l

1.04

765

2119

Other arrhythmias

497

1378

2.74

87.87

1.5

1.4

2785.92

3789.01

e6/l

0.65

364

1016

Hypertensive Heart Disease

381

958

3.18

87.08

1.5

1.4

1683.24

4363.55

e6/l

1.43

275

700

Opioids

820

1909

2.25

86.30

1.5

1.4

2209.05

3317.04

e6/l

1.30

576

1378

Diabetic nephropathy, excluding more controls

255

527

4.11

85.32

1.6

1.5

1275.24

3562.57

e6/l

1.82

187

364

All influenza

277

766

3.67

85.12

1.6

1.4

1358.14

2256.62

e6/l

1.90

204

551

L01XE Protein kinase inhibitors

143

233

6.53

84.80

1.4

1.5

1693.25

1788.80

e6/l

0.12

113

163

Cerebrovascular diseases (FINNGEN)

252

426

4.23

84.60

1.6

1.3

4080.10

3833.56

e6/l

0.05

192

314

COPD, early/later onset

646

2352

2.35

84.42

1.4

1.5

3284.06

2832.84

e6/l

0.21

482

1708

Other chronic obstructive pulmonary disease, including avohilmo

702

2596

2.27

84.01

1.4

1.5

3032.87

2819.63

e6/l

0.11

526

1887

General symptoms and signs

913

2168

2.12

83.16

1.5

1.4

3601.50

2975.20

e6/l

0.29

669

1559

COPD, hospital admissions

639

2346

2.34

82.57

1.4

1.5

3337.31

2829.00

e6/l

0.24

475

1706

Codes for special purposes

570

2398

2.40

81.28

1.5

4350.01

2330.89

e6/l

0.75

371

1761

Provisional assignment of new diseases of uncertain etiology

569

2392

2.40

81.27

1.5

4359.07

2333.16

e6/l

0.75

370

1758

Any reimbursement code in KELA

302

387

3.93

80.97

1.5

1.3

2866.20

5800.74

e6/l

1.04

204

289

Complications of procedures, not elsewhere classified

797

3149

2.11

80.78

1.5

3807.74

3063.73

e6/l

0.24

594

2287

Hypertensive diseases (excluding secondary)

314

505

3.64

80.66

1.6

1.3

2239.70

4154.52

e6/l

2.33

223

372

COPD related to multimorbidity

591

2123

2.39

80.18

1.5

3366.89

2793.11

e6/l

0.26

444

1539

malignant neoplasm of female genital organs

174

352

5.02

80.15

1.3

1.4

1356.23

2085.05

e6/l

0.82

122

256

Pulmonary embolism

424

1570

2.75

79.64

1.4

1.5

2125.26

2861.60

e6/l

0.72

303

1131

Undetermined asthma, excluding more controls

13.91

79.17

1.5

1.1

4127.10

2073.13

e6/l

1.58

Metabolic disorders

880

2620

2.06

78.61

1.5

3136.13

3165.62

e6/l

0.01

622

1922

Peripheral artery disease

636

2233

2.30

78.33

1.5

1322.22

3157.13

e6/l

2.71

454

1657

Allergic asthma (mode), excluding more controls

11.02

78.21

1.4

1.1

2772.27

2172.71

e6/l

0.37

Pulmonary heart disease

424

1590

2.72

77.71

1.4

1.5

2125.26

2834.00

e6/l

0.69

303

1146

Symptoms and signs involving the circulatory and respiratory systems

779

1784

2.20

77.51

1.5

1.4

2346.39

3348.40

e6/l

0.96

579

1248

Covid-19 confirmed case

471

1863

2.57

77.34

1.5

3878.79

2337.84

e6/l

0.48

299

1374

Neoplasms

515

1039

2.64

76.72

1.4

2826.54

5572.76

e6/l

1.41

362

760

Paroxysmal tachycardia

194

357

4.60

76.69

1.5

1.3

1568.62

3667.13

e6/l

3.12

144

271

Percutaneous Coronary Intervention

770

2213

2.15

76.42

1.5

1.4

3019.36

3813.11

e6/l

0.42

564

1603

Pleural plaque

156

303

5.32

76.26

1.4

1.2

3777.30

3136.13

e6/l

0.11

133

196

DVT of lower extremities and pulmonary embolism

540

2298

2.37

74.83

1.4

1.5

2144.44

2661.93

e6/l

0.57

387

1664

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

276

477

3.68

74.34

1.5

1.3

5880.42

3913.68

e6/l

0.25

200

354

Ulcer of lower limb, not elsewhere classified

262

768

3.52

74.32

1.6

1.5

2141.65

1854.98

e6/l

0.15

173

561

COPD, hospital admissions 3, with asthma pneumonia sepsis

453

1515

2.61

73.80

1.5

3227.12

1966.03

e6/l

0.83

333

1093

Venous thromboembolism

646

2889

2.19

73.31

1.5

3263.18

2655.84

e6/l

0.24

466

2102

Infections, IBD-co-morbidities

216

370

4.24

72.74

1.6

1.4

3472.36

3615.66

e6/l

0.02

162

253

Other CVD (FINNGEN)

153

216

5.62

72.67

1.7

1.3

15563.47

2650.21

e6/l

0.96

111

164

Viral pneumonia

167

358

4.77

72.53

1.6

1.4

1526.00

2030.44

e6/l

0.68

126

261

Emergency coronary revascularization (for ACS)

851

2571

2.03

72.49

1.5

2845.92

3729.28

e6/l

0.55

621

1867

COPD, hospital admission 2, with asthma infections

493

1739

2.48

72.31

1.5

3156.95

1990.84

e6/l

0.85

365

1260

Coronary revascularization (ANGIO or CABG)

756

2213

2.11

71.44

1.5

1.4

3037.65

3813.11

e6/l

0.40

553

1603

L04AD Calcineurin inhibitors

156

321

5.00

71.27

1.7

1.4

1278.67

2671.67

e6/l

2.13

108

238

Asthma-related pneumonia

473

1944

2.46

71.27

1.5

2511.58

2505.94

e6/l

0.00

345

1403

Asthma, hospital admissions 3, pneumonia

473

1945

2.46

71.18

1.5

2511.58

2504.37

e6/l

0.01

345

1404

Asthma-related pneumonia or sepsis

473

1945

2.46

71.18

1.5

2511.58

2504.37

e6/l

0.01

345

1404

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

12.67

71.05

1.4

1340.09

1403.39

e6/l

0.06

Caries of dentine

308

989

3.08

71.03

1.6

1.5

5208.78

2670.66

e6/l

0.37

217

715

Complications of medical and surgical care

733

3301

2.06

70.94

1.5

4012.10

3010.27

e6/l

0.31

525

2411

Hyperkalaemia

140

266

5.53

70.53

1.6

1.4

804.04

2248.41

e6/l

2.36

197

Dental caries

333

1107

2.94

70.47

1.6

1.5

5025.14

2869.18

e6/l

0.33

236

803

Explicit bacterial Sepsis

175

403

4.47

69.68

1.6

1.4

7063.78

1773.17

e6/l

0.45

118

306

Non-allergic asthma (mode)

113

174

6.49

68.97

1.6

1.2

3380.50

1331.16

e6/l

1.10

114

Atherosclerosis, excluding cerebral and coronary sclerosis

598

2150

2.24

68.75

1.5

1341.59

3159.24

e6/l

2.49

426

1595

Major coronary heart disease event

794

2390

2.02

66.90

1.5

1.4

2869.48

3854.54

e6/l

0.59

587

1734

Dialysis

112

8.27

65.22

1.6

1.4

470.98

2352.45

e6/l

3.24

Cardiomyopathy, other and unspecified

118

206

5.90

64.76

1.6

1.3

9511.87

2502.62

e6/l

0.37

148

Pacemaker

495

2086

2.32

64.04

1.6

1.5

1267.62

2655.00

e6/l

2.54

359

1514

Malignant neoplasm of digestive organs

395

1212

2.60

63.78

1.4

1.5

1745.46

3441.13

e6/l

1.15

288

893

ILD medications: immunosuppressive drugs

535

2251

2.22

63.52

1.5

1.4

3298.26

3713.50

e6/l

0.21

374

1618

Malignant neoplasm of ovary

9.21

63.49

1.2

1.5

1636.85

1488.29

e6/l

0.10

Cardiovascular diseases

281

450

3.37

63.24

1.5

1.3

3407.31

4380.29

e6/l

0.54

196

330

Hard cardiovascular diseases

723

2119

2.05

63.17

1.5

2970.89

4085.24

e6/l

0.62

534

1528

Streptococcal septicaemia

155

355

4.51

62.31

1.5

1.4

7554.48

1967.40

e6/l

0.44

109

260

Iron deficiency anaemia

495

2173

2.27

62.13

1.5

4604.31

2679.18

e6/l

0.43

360

1574

Pain in throat and chest

626

1768

2.14

61.33

1.5

1.4

4099.19

3134.16

e6/l

0.26

454

1235

Abscess of lung

12.98

61.03

1.4

1.3

18292.74

1567.32

e6/l

1.05

Adjustment and management of implanted device

270

911

3.03

60.55

1.6

1.4

1437.94

2407.40

e6/l

1.34

155

664

Other diseases of the respiratory system

317

1169

2.77

60.33

1.6

1.5

3975.07

2079.55

e6/l

0.89

257

835

Other respiratory disorders and diseases

317

1169

2.77

60.33

1.6

1.5

3975.07

2079.55

e6/l

0.89

257

835

Insulin medication

631

2599

2.06

60.29

1.7

1.4

1577.00

3421.24

e6/l

2.92

461

1896

Malignant neoplasm of breast, HER2-negative, including Hilmo

272

555

3.20

60.21

1.3

1.4

4296.82

3606.72

e6/l

0.11

203

401

Malignant neoplasm of breast, including Hilmo

272

555

3.20

60.20

1.3

1.4

4296.82

3606.72

e6/l

0.11

203

401

Polyarthropathies

689

2235

2.03

59.98

1.6

1.4

2471.62

3488.59

e6/l

0.87

493

1612

Malignant neoplasm of breast, HER2-negative

267

550

3.20

59.41

1.3

1.4

4331.53

3595.66

e6/l

0.11

201

398

Secondary hypertension

157

6.37

58.76

1.5

1.3

862.38

2767.48

e6/l

4.71

110

Malignant neoplasm of breast

266

551

3.17

58.34

1.3

1.4

4315.48

3593.22

e6/l

0.11

201

399

Ischemic heart diseases

731

2235

1.98

58.20

1.5

1.4

2980.18

3806.06

e6/l

0.43

537

1620

Serous carcinoma of ovary, including Hilmo

10.50

57.94

1.2

1.4

1783.79

1329.22

e6/l

0.33

Non-Hodgkin lymphoma, all, including Hilmo

173

457

3.87

57.24

1.5

2031.70

2968.79

e6/l

0.70

125

336

Oedema, not elsewhere classified

349

1363

2.56

57.14

1.6

1.4

2049.52

2005.63

e6/l

0.03

248

978

Primary_lymphoid and hematopoietic malignant neoplasms

333

1295

2.62

56.99

1.6

1.5

2656.11

2543.26

e6/l

0.06

246

941

Diabetic nephropathy

259

874

3.01

56.82

1.6

1.5

1272.28

3223.51

e6/l

1.01

189

621

Certain infectious and parasitic diseases

597

1401

2.15

56.22

1.6

1.4

2237.55

3454.03

e6/l

1.02

423

1038

Hypertension, essential

586

1567

2.13

55.99

1.5

1.4

1821.71

4927.74

e6/l

3.10

413

1149

Codeine

694

1892

2.00

55.98

1.5

1.4

4039.35

3339.43

e6/l

0.18

503

1365

Amputation

186

527

3.64

55.74

1.6

1.4

2041.39

1913.49

e6/l

0.06

127

393

Nutritional anaemias

554

2611

2.07

54.66

1.5

4231.31

2603.49

e6/l

0.41

408

1892

Other disorders of skin and subcutaneous tissue

687

3207

1.92

54.27

1.5

3374.96

2756.42

e6/l

0.23

499

2332

Calcific aortic valvular stenosis, operated

445

1957

2.24

53.68

1.6

1.5

1458.47

2196.62

e6/l

1.00

319

1426

Calcific aortic valvular stenosis

445

1957

2.24

53.68

1.6

1.5

1458.47

2196.62

e6/l

1.00

319

1426

Secondary and unspecified malignant neoplasm of lymph nodes

119

249

4.91

53.44

1.8

1.5

1864.34

1603.15

e6/l

0.37

175

Calcific aortic valvular stenosis, diagnosis (helper)

443

1956

2.23

52.92

1.6

1.5

1460.11

2198.03

e6/l

1.00

318

1425

Operations 2 for CAVS

443

1956

2.23

52.92

1.6

1.5

1460.11

2198.03

e6/l

1.00

318

1425

Preparatory care for dialysis

103

194

5.60

52.57

1.6

1.4

1508.87

1714.11

e6/l

0.08

137

Type 2 diabetes, wide definition

745

2549

1.88

52.29

1.5

1.4

1769.53

3523.96

e6/l

3.18

520

1872

Calcific aortic valvular stenosis, including rheumatic fever

443

1964

2.22

52.26

1.6

1.5

1460.11

2192.30

e6/l

0.99

318

1431

Hernia of abdominal wall, postoperative

160

432

3.75

51.14

1.5

1.4

3710.02

4497.82

e6/l

0.15

112

307

Care involving use of rehabilitation procedures

493

2168

2.11

51.03

1.4

5774.03

3480.64

e6/l

0.55

369

1577

Hypertensive diseases

571

1575

2.06

50.06

1.5

1.4

1873.13

4939.84

e6/l

3.03

407

1155

Malignant neoplasm of other and unspecified female genital organs

15.90

49.91

1.5

1.3

1557.10

1139.14

e6/l

0.40

Hypertension

570

1575

2.05

49.72

1.5

1.4

1876.88

4939.84

e6/l

3.02

406

1155

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

591

3025

1.94

49.51

1.5

4247.18

2851.17

e6/l

0.37

432

2207

Malignant neoplasm of breast, HER-positive

211

521

3.19

49.19

1.4

4362.74

3701.92

e6/l

0.08

155

377

STROKE

461

1445

2.19

49.19

1.5

1.4

1988.68

3784.07

e6/l

2.09

347

1038

Malignant neoplasm of breast, ER-positive, including Hilmo

213

523

3.17

49.08

1.4

4336.65

3685.28

e6/l

0.08

156

379

Insulin, combination of fast acting with intermediate-acting or long-acting

632

3062

1.90

48.91

1.7

1.4

1574.37

3214.88

e6/l

2.95

462

2230

Nonischemic cardiomyopathy

154

421

3.75

48.60

1.5

1.4

9627.63

2400.12

e6/l

0.54

100

304

Endocarditis

8.51

48.18

1.7

1.2

8120.80

2931.81

e6/l

0.32

Disorders of lipoprotein metabolism and other lipidaemias

744

2525

1.84

48.01

1.5

2202.73

3125.02

e6/l

1.02

512

1859

Insulin, fast-acting

377

1674

2.28

47.92

1.7

1.4

1286.48

2538.06

e6/l

3.22

275

1206

Hypothyroidism (congenital or acquired)

6.80

47.74

1.6

1.3

1990.15

4996.81

e6/l

1.89

Chronic lower respiratory diseases

967

3030

1.71

47.26

1.5

3620.99

3116.30

e6/l

0.20

709

2179

Hypo-osmolality and hyponatraemia

238

854

2.82

47.25

1.6

1.5

5509.34

2398.17

e6/l

0.66

196

623

Myocardial infarction

522

1814

2.04

47.15

1.5

2802.21

4002.35

e6/l

0.53

389

1315

Coronary atherosclerosis

622

2051

1.93

47.11

1.5

2189.00

3864.48

e6/l

1.26

453

1489

Later onset COPD

431

1599

2.19

46.99

1.5

2146.44

1859.44

e6/l

0.31

321

1150

Depression medications

107

6.36

46.87

1.6

1.3

3244.96

5690.43

e6/l

1.22

Anaemia in chronic diseases classified elsewhere

7.79

46.76

1.5

1.4

1438.48

2294.59

e6/l

0.56

Gout

403

1623

2.22

46.74

1.6

1.4

1717.45

3490.83

e6/l

1.52

286

1186

Undetermined asthma

109

6.76

46.54

1.5

1.2

4127.10

1265.85

e6/l

3.05

Major coronary heart disease event excluding revascularizations

608

2117

1.93

46.27

1.6

1.5

2932.24

3940.49

e6/l

0.49

448

1537

Other and unspecified iron deficiency

369

1649

2.26

46.24

1.6

1.5

5579.14

2837.88

e6/l

0.45

258

1200

Hypothyroidism and >3 levothyroxin purchases

6.76

46.10

1.6

1.3

2006.16

5048.68

e6/l

1.88

Hypothyroidism, levothyroxine purchases

6.76

46.10

1.6

1.3

2006.16

5048.68

e6/l

1.88

Allergic asthma (mode)

142

5.82

46.02

1.4

1.2

2772.27

1460.48

e6/l

1.24

Peripheral arterial reconstruction

279

1109

2.57

45.91

1.5

1441.94

2272.88

e6/l

0.93

203

805

Gout, FINNGEN

403

1881

2.17

45.26

1.6

1.4

1717.45

2791.13

e6/l

1.02

286

1373

Diseases of oesophagus, stomach and duodenum

882

3089

1.72

45.10

1.5

1.4

4128.29

2945.45

e6/l

0.49

634

2248

Other dialysis

108

6.95

45.05

1.7

1.4

431.30

2385.71

e6/l

3.20

Dilated cardiomyopathy

191

631

3.11

44.76

1.5

6344.14

1979.10

e6/l

0.41

133

451

Insulin, intermediate and long-acting

558

2857

1.91

44.55

1.7

1.4

1450.35

3290.29

e6/l

3.27

411

2081

Hypothyroidism, drug reimbursement

8.85

44.53

1.6

1.2

2695.24

5071.98

e6/l

0.68

Type 1 diabetes

242

908

2.69

44.31

1.6

1.5

1240.96

2512.69

e6/l

2.18

178

665

Parasetamol

559

1423

2.00

44.25

1.5

1.4

2930.03

2642.27

e6/l

0.22

396

1015

ILD, hospital admissions 3, with pneumonia sepsis

123

308

4.10

44.04

1.6

1.3

5493.60

1694.52

e6/l

0.68

228

Non-small cell lung cancer, squamous

189

5.11

43.43

1.4

1576.57

1577.01

e6/l

0.00

131

Amputation of toe

136

375

3.76

42.69

1.6

1.5

2491.90

1763.34

e6/l

0.30

273

Insulin, fast-acting or short human

379

1777

2.15

42.17

1.7

1.5

1282.81

2599.96

e6/l

3.54

276

1283

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

207

739

2.86

42.13

1.8

1.5

9942.85

1921.64

e6/l

0.80

144

535

Autoimmune diseases excluding thyroid diseases

867

2795

1.70

42.12

1.6

1.4

3060.06

3161.06

e6/l

0.06

645

2021

Asthma-related infections

533

2764

1.90

41.93

1.5

2519.83

3238.60

e6/l

0.65

393

1988

Asthma, hospital admission 2, infections

533

2764

1.90

41.93

1.5

2519.83

3238.60

e6/l

0.65

393

1988

ILD, hospital admission 2, with pulmonary infections

129

346

3.81

41.91

1.6

1.4

5393.85

1895.11

e6/l

0.62

256

Peripheral artery operations in Hilmo

203

719

2.89

41.91

1.5

1.4

1983.47

2030.04

e6/l

0.02

139

529

Autoimmune diseases excluding thyroid diseases, strict definition

842

2710

1.71

41.73

1.6

1.4

3076.99

3214.19

e6/l

0.07

624

1960

Enterocolitis due to Clostridium difficile

165

523

3.23

41.46

1.6

1.4

3572.08

2118.55

e6/l

0.27

128

381

Other bacterial intestinal infections

221

826

2.72

41.08

1.6

1.5

3046.73

2011.82

e6/l

0.26

175

602

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

207

332

3.14

41.08

1.4

1.3

1953.23

4924.23

e6/l

1.03

143

231

Kidney transplant status

146

5.59

40.97

1.7

1.4

832.69

2295.49

e6/l

2.60

105

L04AA Selective immunosuppressants

211

775

2.76

40.49

1.7

1.5

3075.03

2207.33

e6/l

0.47

142

562

COPD-related respiratory insufficiency

190

667

2.92

40.01

1.4

1.5

3734.37

1783.83

e6/l

0.56

148

475

542

2641

1.87

39.84

1.5

7866.38

2474.70

e6/l

1.59

401

1915

Type 1 diabetes, wide definition, subgroup 1

189

667

2.86

39.01

1.6

1.5

1336.59

2466.12

e6/l

1.31

137

492

Malignant neoplasm of skin

401

1322

2.09

38.71

1.4

1.5

2168.15

3612.77

e6/l

0.95

279

973

Implicit fungal Sepsis

237

4.30

37.73

1.7

1.3

1951.99

1586.75

e6/l

0.40

177

Alcohol use disorder, Swedish definition

517

2574

1.86

37.31

1.5

8140.42

2502.92

e6/l

1.59

383

1863

Intestinal infectious diseases

758

3451

1.67

37.30

1.5

1.4

2509.11

3444.40

e6/l

0.71

565

2489

Substance abuse, excluding more controls

501

2288

1.88

37.24

1.5

9193.31

2204.11

e6/l

2.07

379

1634

550

2681

1.82

37.04

1.5

7747.27

2509.35

e6/l

1.56

409

1943

Disorders resulting from impaired renal tubular function

136

5.54

36.64

1.6

1.4

706.66

2084.27

e6/l

2.41

100

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

127

370

3.51

36.54

1.5

1477.60

3019.66

e6/l

1.18

269

Pure hypercholesterolaemia

657

2470

1.75

36.54

1.5

2312.14

3122.76

e6/l

0.79

467

1819

Diseases of the digestive system

481

2572

1.88

36.46

1.6

1.5

4596.50

2596.20

e6/l

0.49

365

1861

Bacterial intestinal infections, IBD co-morbidities

218

860

2.57

36.41

1.6

1.5

3090.65

1975.79

e6/l

0.28

172

628

Cardiodefibrillation

431

2236

1.95

36.30

1.6

1.5

1571.36

3058.33

e6/l

1.78

307

1634

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

389

1289

2.06

36.03

1.4

1.5

2266.93

3668.20

e6/l

0.87

269

946

Diseases of liver

330

1567

2.13

35.71

1.7

1.5

7376.41

2406.14

e6/l

0.80

234

1140

Enlarged lymph nodes

162

554

2.96

35.59

1.5

1.4

1930.94

2378.91

e6/l

0.63

120

387

Coronary artery bypass grafting

347

1228

2.14

35.56

1.5

1190.99

3526.54

e6/l

2.29

250

901

COPD, hospital admissions 1, only main diagnosis

434

1933

1.95

35.54

1.4

1.5

2853.49

2071.42

e6/l

0.54

321

1407

Other bacterial intestinal infections

243

1020

2.41

35.46

1.6

1.5

3000.42

2098.06

e6/l

0.24

187

728

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

524

2913

1.81

35.43

1.5

4147.87

2811.94

e6/l

0.31

382

2116

Malignant neoplasm, without specification of site, including Hilmo

171

4.83

35.17

1.3

1.5

1896.14

1518.37

e6/l

0.26

121

Type 1 diabetes, wide definition

197

751

2.65

35.10

1.6

1.5

1369.73

2424.24

e6/l

1.26

142

554

Gout, idiopatic and unspecified

330

1595

2.10

34.29

1.7

1.5

1606.05

2410.87

e6/l

1.13

228

1162

Mental and behavioural disorders due to psychoactive substance use

516

2666

1.81

34.25

1.5

8931.42

2495.39

e6/l

1.91

392

1932

Cirrhosis of liver, NAS

242

4.07

33.48

1.9

1.4

1322.04

1633.07

e6/l

0.46

180

Other malignant neoplasms of skin (=non-melanoma skin cancer)

367

1241

2.04

33.28

1.4

1.5

2186.77

3545.13

e6/l

0.79

251

913

Fungal Sepsis

148

5.05

33.27

1.6

1.4

2148.33

1534.25

e6/l

0.58

111

Substance abuse

501

2630

1.80

33.15

1.5

9193.31

2460.09

e6/l

1.95

379

1907

GI-bleeding

381

1964

1.96

32.94

1.6

1.5

4950.67

2308.21

e6/l

0.54

293

1404

Fibrosis and cirrhosis of liver

118

352

3.45

32.88

1.8

1.4

1430.22

1813.81

e6/l

0.60

259

Diarrhoea and gastroenteritis of presumed infectious origin

555

2877

1.75

32.87

1.5

2198.67

3564.88

e6/l

1.60

407

2055

Malignant neoplasm of urinary organs

118

352

3.42

32.77

1.4

1.5

1434.26

2622.72

e6/l

0.94

259

Other diseases of blood and blood-forming organs, wide

231

983

2.38

32.76

1.5

5900.89

2241.24

e6/l

0.49

182

708

Iron deficiency anaemia secondary to blood loss (chronic)

194

764

2.58

32.61

1.5

1737.96

2125.24

e6/l

0.28

157

557

Diabetes mellitus

758

2722

1.63

32.43

1.5

1.4

2616.67

3499.41

e6/l

0.65

527

1992

Diabetes, varying definitions

756

2724

1.63

32.32

1.5

1.4

2622.27

3501.31

e6/l

0.64

527

1991

Gout, strict definition

256

1149

2.27

32.22

1.7

1.5

1543.64

2307.27

e6/l

0.80

177

840

Basal cell carcinoma

358

1228

2.03

32.12

1.4

1.5

2221.51

3546.63

e6/l

0.75

241

902

Other diseases of the digestive system

378

1961

1.95

32.10

1.6

1.5

5007.08

2322.97

e6/l

0.54

289

1401

Antihypertensive medication - note that there are other indications

274

627

2.32

32.01

1.5

1.4

2836.42

4617.09

e6/l

1.31

184

457

Cerebrovascular diseases

699

3002

1.65

31.81

1.5

2858.83

3196.31

e6/l

0.17

516

2179

Type 2 diabetes

746

2692

1.63

31.27

1.5

1.4

2702.62

3506.89

e6/l

0.56

524

1973

Dipeptidyl peptidase 4 (DPP-4) inhibitors

559

2615

1.73

30.95

1.6

1.5

1943.98

3395.15

e6/l

1.69

409

1906

Basal cell carcinoma, including avohilmo

359

1244

2.00

30.93

1.4

1.5

2248.38

3536.13

e6/l

0.73

240

915

Myocardial infarction, strict

454

1767

1.85

30.80

1.5

1550.79

4050.28

e6/l

2.70

335

1281

Implicit fungal Sepsis

131

5.15

30.74

1.6

1.4

2190.43

1392.08

e6/l

0.76

Cough

299

1367

2.08

30.58

1.5

1.4

2060.86

2652.55

e6/l

0.48

238

954

885

2941

1.56

30.50

1.5

1.4

2807.24

3262.51

e6/l

0.29

658

2113

Benign neoplasm of colon, rectum, anus and anal canal

614

3218

1.67

30.49

1.5

1871.63

3301.93

e6/l

2.25

431

2364

Malignant neoplasm of kidney, except renal pelvis

108

320

3.45

30.36

1.4

1.5

1559.17

2589.12

e6/l

0.69

235

Ischaemic heart disease, wide definition

652

2442

1.66

30.17

1.5

3114.74

3712.13

e6/l

0.25

480

1766

Gout, unspecified

272

1286

2.15

30.06

1.7

1.5

1690.36

2474.84

e6/l

0.85

192

935

Examination and observation for other reasons

483

1551

1.81

29.74

1.6

1.4

4283.99

2558.32

e6/l

0.44

369

1055

Vocal cord dysfunction

113

307

3.34

29.70

1.6

1.4

2522.29

3064.45

e6/l

0.34

220

Other acute lower respiratory infections

468

2529

1.77

29.59

1.5

4538.49

2610.16

e6/l

0.74

348

1838

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

138

327

3.04

28.95

1.6

1.4

5255.93

3580.94

e6/l

0.20

222

Disorders of choroid and retina

721

3233

1.59

28.92

1.5

4313.43

2792.84

e6/l

0.46

522

2352

Disorders of lens

588

2187

1.69

28.85

1.5

2861.46

3479.32

e6/l

0.29

414

1603

Infections of the skin and subcutaneous tissue

449

2514

1.78

28.85

1.6

1.5

4440.26

3433.14

e6/l

0.19

332

1817

All influenza (not pneumonia)

112

350

3.23

28.78

1.6

1.4

1680.81

2319.85

e6/l

0.56

265

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

715

2696

1.60

28.67

1.5

1.4

1920.44

3512.83

e6/l

2.72

501

1976

Syncope and collapse

387

1783

1.87

28.57

1.5

1.4

6121.54

2434.37

e6/l

0.74

285

1293

Acute peritonitis

270

3.61

28.57

1.6

1.4

1150.64

1690.98

e6/l

0.75

193

Other CVD

254

1194

2.16

28.48

1.6

1.5

9723.67

2174.23

e6/l

0.94

188

859

Endocrine, nutritional and metabolic diseases

513

1475

1.77

28.34

1.5

1.4

2616.71

3505.79

e6/l

0.77

358

1075

Use of hypnotics and sedatives

827

3079

1.55

28.20

1.5

3972.70

3099.19

e6/l

0.31

613

2233

Diabetes, insulin treatment (Kela reimbursement)

787

3057

1.56

28.16

1.5

1.4

1855.50

3697.61

e6/l

3.09

551

2228

Fall on same level

827

2927

1.55

27.93

1.6

1.4

5199.17

2868.91

e6/l

0.82

593

2116

Bronchitis

824

3404

1.53

27.20

1.5

2847.48

3224.35

e6/l

0.24

616

2456

Hypertensive Renal Disease

171

4.30

27.05

1.6

1.4

478.79

1943.07

e6/l

5.52

131

Chronic lymphocytic leukaemia, helper endpoint

5.59

26.87

1.7

1.5

2005.02

1635.94

e6/l

0.25

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

5.59

26.87

1.7

1.5

2005.02

1635.94

e6/l

0.25

Chronic lymphocytic leukaemia

5.59

26.87

1.7

1.5

2005.02

1635.94

e6/l

0.25

Pain, not elsewhere classified

208

922

2.27

26.83

1.6

1.4

4862.14

2152.11

e6/l

1.66

147

660

Myocardial infarction, without ST-elevation

470

2502

1.73

26.78

1.4

1.5

1865.76

2813.19

e6/l

0.74

353

1820

Diabetes medication

767

2941

1.55

26.70

1.5

1.4

2646.46

3728.68

e6/l

0.79

538

2146

Heart failure and hypertrophic cardiomyopathy

6.18

26.54

1.9

1.3

692.11

1937.84

e6/l

2.24

Amiodarone users

145

551

2.69

26.45

1.5

1166.47

1720.29

e6/l

0.83

103

405

Diabetic retinopathy, excluding more controls

239

600

2.26

26.43

1.5

4757.44

3290.15

e6/l

0.16

181

416

Early onset COPD

224

1033

2.19

26.36

1.4

1.5

5391.70

2041.20

e6/l

1.03

168

739

Disorders of gallbladder, biliary tract and pancreas

792

3275

1.53

26.23

1.5

3274.26

3035.29

e6/l

0.07

574

2379

Osteopathies and chondropathies

459

2499

1.72

26.07

1.5

2699.61

3432.31

e6/l

0.52

339

1787

Cardiomyopathy, Hypertrophic obstructive

8.83

25.94

1.6

1.2

697.92

2072.96

e6/l

1.66

Asthma and allergy, excluding more controls

9.31

25.75

1.8

1.2

3118.73

2687.57

e6/l

0.11

Mental and behavioural disorders due to alcohol

437

2435

1.74

25.71

1.5

9066.57

2539.35

e6/l

1.58

328

1766

Lung transplant status

29.70

25.59

1.6

1.5

2310.39

1300.57

e6/l

—

Lung transplantation

29.67

25.58

1.6

1.5

2310.39

1300.57

e6/l

—

Stroke, including SAH

612

2783

1.61

25.46

1.5

1970.08

3028.56

e6/l

1.36

452

2013

Invasive ventilation

301

3.30

25.44

1.5

1.4

975.98

1707.98

e6/l

2.77

216

Gastroduodenal ulcer

306

1599

1.93

25.37

1.5

5715.56

2290.63

e6/l

0.56

230

1154

Symptoms and signs involving the urinary system

650

3157

1.58

25.34

1.5

4144.96

2943.10

e6/l

0.48

471

2297

Non-Hodgkin lymphoma, all

163

4.24

25.16

1.7

1.5

1916.19

1463.76

e6/l

0.54

113

Alcoholic liver disease

128

468

2.79

25.13

1.7

1.4

14977.22

2037.70

e6/l

0.82

334

Convulsions, not elsewhere classified

182

774

2.34

25.10

1.5

12142.16

2480.14

e6/l

1.01

132

557

Mental and behavioural disorders due to alcohol, excluding acute intoxication

388

2190

1.78

24.83

1.5

10133.10

2635.76

e6/l

1.60

287

1584

Used for control exclusion in common control thyroid runs

785

2603

1.53

24.74

1.6

1.4

3723.40

3238.76

e6/l

0.15

576

1885

Other retinal disorders

599

2941

1.60

24.69

1.5

3096.43

2490.33

e6/l

0.23

440

2149

Benign neoplasm: Colon

523

3072

1.64

24.61

1.5

1970.28

2994.65

e6/l

1.35

372

2251

Glomerulonephritis

115

402

2.91

24.54

1.5

1.4

1180.71

1995.45

e6/l

1.55

298

Intestinal stricture

317

1707

1.88

24.18

1.4

1.5

2460.77

2622.46

e6/l

0.08

222

1234

Hypokalaemia

125

461

2.75

24.09

1.4

9177.89

2377.29

e6/l

0.47

343

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

8.38

24.08

1.8

1.3

793.18

1858.86

e6/l

1.25

Other disorders of glucose regulation and pancreatic internal secretion

306

3.19

24.05

1.6

1.4

13060.86

1769.05

e6/l

0.55

225

Abnormal findings on examination of blood, without diagnosis

463

2547

1.68

24.04

1.6

1.5

2018.95

2891.83

e6/l

0.92

332

1876

Sub-endpoint used in defining T1D endpoints

261

1296

2.00

24.03

1.6

1.5

1187.45

2253.54

e6/l

1.97

192

929

Other abnormalities of plasma proteins

6.68

23.84

2.0

1.2

1707.31

1731.02

e6/l

0.01

Other disorders of kidney and ureter

152

621

2.49

23.83

1.6

1.5

1315.93

2076.70

e6/l

0.88

452

Agranulocytosis

121

442

2.78

23.78

1.5

8986.48

2197.75

e6/l

0.48

316

Pneumonia derived septicemia

124

4.67

23.74

1.3

1592.08

1692.27

e6/l

0.07

Symptoms and signs involving the digestive system and abdomen

765

2527

1.52

23.62

1.5

2868.23

3610.79

e6/l

0.55

552

1837

Fentanyl

126

471

2.71

23.61

1.6

1.5

1782.18

2048.44

e6/l

0.18

107

351

Viral hepatitis, IBD co-morbidity

5.12

23.55

1.5

1.4

30633.00

2330.07

e6/l

0.73

Codeine or tramadol medication

848

3148

1.48

23.26

1.5

3978.96

3043.37

e6/l

0.33

610

2286

Injuries to the head

815

3389

1.48

23.23

1.5

4972.97

2885.18

e6/l

0.79

601

2444

Oesophageal varices

165

4.07

23.10

1.9

1.5

991.54

1872.63

e6/l

2.07

115

Clear cell adenocarcinoma of kidney

144

4.28

22.95

1.4

1.5

1276.65

1635.74

e6/l

0.49

102

Intestinal infectious diseases

867

3391

1.47

22.93

1.5

2502.14

3507.00

e6/l

0.86

639

2453

Nausea and vomiting

235

1139

2.04

22.91

1.6

1.5

3469.82

2726.35

e6/l

0.16

173

814

Symptoms and signs concerning food and fluid intake

111

396

2.84

22.73

1.5

1.4

1802.42

2060.21

e6/l

0.28

285

Unspecified acute lower respiratory infection

149

617

2.45

22.65

1.4

1.5

6779.66

2290.69

e6/l

0.67

108

444

Pneumococcal septicemia

121

4.61

22.58

1.3

1527.89

1673.38

e6/l

0.11

Pneumonia due to Streptococcus pneumoniae

5.34

22.55

1.4

20767.28

1554.06

e6/l

0.51

Non-small cell lung cancer, squamous, helper endpoint

305

3.15

22.41

1.4

1.5

1576.57

1980.24

e6/l

0.43

217

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

752

3239

1.49

22.27

1.6

1.5

3085.68

3242.63

e6/l

0.04

543

2358

Injuries to the thorax

409

2440

1.69

21.88

1.5

4018.86

3400.36

e6/l

0.20

301

1768

Abnormalities of heart beat

250

1260

1.96

21.84

1.6

1.4

2488.67

2598.99

e6/l

0.05

189

872

Autoimmune diseases

811

2803

1.48

21.77

1.6

1.4

3723.91

3161.49

e6/l

0.19

598

2025

Fracture of femur

312

1564

1.83

21.63

1.4

1.5

4580.42

2634.31

e6/l

0.28

224

1122

Chronic pancreatitis

136

553

2.50

21.58

1.5

1.4

9019.15

2206.48

e6/l

0.50

100

399

Asthma/COPD (KELA code 203)

665

3025

1.51

21.31

1.5

4646.30

3115.21

e6/l

0.49

498

2175

Stroke, excluding SAH

579

2740

1.55

21.01

1.5

1832.49

3015.84

e6/l

1.61

429

1972

Malignant neoplasm of breast, ER-negative, including Hilmo

125

468

2.56

20.97

1.4

2796.32

2953.82

e6/l

0.04

336

Hypoglycaemia, other or unspecified

244

3.30

20.92

1.7

1.4

14120.89

1729.77

e6/l

0.48

181

Asthma (diagnoses ohter than nonallergic)

644

3559

1.51

20.91

1.5

3144.38

3217.23

e6/l

0.04

469

2581

Paralytic ileus and intestinal obstruction

265

1415

1.89

20.81

1.5

2802.05

2712.58

e6/l

0.03

185

1023

Misadventures to patients during surgical and medical care

140

587

2.42

20.76

1.7

1.4

2570.79

2297.19

e6/l

0.09

108

431

Secondary malignant neoplasm of respiratory and digestive organs

6.61

20.76

1.3

840.03

1795.87

e6/l

1.01

Factors influencing health status and contact with health services

225

539

2.11

20.72

1.5

1.4

1724.66

3692.23

e6/l

2.14

165

379

Cardiac arrest

152

3.77

20.55

1.6

1.3

2272.96

3206.77

e6/l

0.32

111

Osteomyelitis

283

3.11

20.55

1.7

1.4

2918.81

1859.14

e6/l

0.37

205

Other soft tissue disorders, not elsewhere classified

686

2691

1.50

20.51

1.5

1.4

2818.71

3076.96

e6/l

0.19

483

1936

Viral pneumonia (known virus, not influenza)

102

4.79

20.49

1.4

1969.81

2046.29

e6/l

0.04

Cellulitis

196

949

2.09

20.44

1.6

1.5

6411.30

2377.46

e6/l

0.43

149

682

Senile cataract

536

2092

1.58

20.31

1.5

1903.92

3259.64

e6/l

1.51

376

1532

Idiopathic gout

128

522

2.50

20.30

1.7

1.5

2576.68

1733.74

e6/l

0.41

377

Pain in limb

603

2650

1.53

20.21

1.5

1.4

2572.68

3087.78

e6/l

0.46

424

1903

Gastric ulcer

203

1001

2.05

20.21

1.4

1.5

3290.59

1887.87

e6/l

0.43

150

718

Sequelae of external causes of morbidity and mortality

235

1220

1.94

20.16

1.6

1.5

2067.73

2370.95

e6/l

0.29

161

886

Other/unspecified cytomegaloviral diseases

7.24

20.07

1.4

1.3

572.24

3266.71

e6/l

1.36

Volume depletion

118

465

2.58

20.05

1.5

1250.06

1871.54

e6/l

1.12

345

Diffuse large B-cell lymphoma, helper endpoint

155

3.91

20.01

1.6

1.5

2139.82

1681.23

e6/l

0.41

111

Diffuse large B-cell lymphoma, including Hilmo

155

3.91

20.01

1.6

1.5

2139.82

1681.23

e6/l

0.41

111

Diffuse large B-cell lymphoma

155

3.91

20.01

1.6

1.5

2139.82

1681.23

e6/l

0.41

111

Chronic viral hepatitis

5.08

19.99

1.5

1.3

34826.62

1993.91

e6/l

0.75

Amputation of foot

139

4.14

19.83

1.6

1.5

820.22

1665.26

e6/l

2.40

105

Other respiratory diseases principally affecting the interstitium

211

1063

2.01

19.83

1.5

3611.63

2205.35

e6/l

0.36

145

784

Decubitus ulcer and pressure area

327

2.91

19.81

1.5

1102.14

1855.52

e6/l

1.77

244

Need for other prophylactic measures

208

3.44

19.76

1.5

1.4

2526.66

1763.41

e6/l

0.53

149

Pneumonia due to other infectious organisms, not elsewhere classified

5.40

19.74

1.6

1.3

2614.50

1363.39

e6/l

0.91

Nephrotic syndrome

101

4.70

19.74

1.6

1.4

1695.00

2349.22

e6/l

0.30

Type 2 diabetes, definitions combined

674

2662

1.49

19.69

1.5

1.4

3087.08

3511.46

e6/l

0.22

466

1954

Charcot foot

7.09

19.67

1.7

1.3

4452.20

1666.14

e6/l

0.38

Left ventricular outflow tract obstruction (LVOTO), broad definition

328

2.88

19.59

1.5

6595.78

2623.52

e6/l

0.45

238

Other cataract

396

1810

1.67

19.45

1.5

2766.03

3035.76

e6/l

0.11

295

1325

Alcohol use disorder, ICD-based

345

2040

1.70

19.20

1.5

10442.54

2607.70

e6/l

1.42

253

1471

Diabetic maculopathy, excluding more controls

111

434

2.59

19.16

1.6

1.4

975.19

1696.02

e6/l

2.37

329

Hyperlipidaemia, other/unspecified

364

2006

1.68

19.12

1.5

1562.65

2588.56

e6/l

2.46

247

1468

Diseases of peritoneum

113

447

2.57

19.07

1.5

1.4

1164.24

2043.99

e6/l

1.31

327

Unspecified haematuria

421

2162

1.63

19.03

1.6

1.5

2664.92

2821.17

e6/l

0.08

303

1588

Coagulation defects, purpura and other haemorrhagic conditions

174

829

2.12

18.99

1.4

1.5

3508.19

2228.53

e6/l

0.35

139

605

Substance use, excluding alcohol

138

598

2.33

18.97

1.4

1.5

17064.05

2748.65

e6/l

1.32

110

426

Type 2 diabetes, strict (exclude DM1)

674

2684

1.48

18.94

1.5

1.4

3069.48

3500.42

e6/l

0.23

466

1969

Polyneuropathies and other disorders of the peripheral nervous system

225

1178

1.93

18.90

1.6

1.5

1672.02

2534.65

e6/l

1.13

163

858

Amyloidosis

4.73

18.88

1.5

1.3

662.81

1208.61

e6/l

1.35

Hypotension

207

1055

1.99

18.85

1.6

1.5

11797.72

2117.76

e6/l

0.97

150

768

Insulin, fast-acting (human)

111

437

2.56

18.84

1.5

1.4

902.00

2384.09

e6/l

4.10

320

Cytomegaloviral disease

6.08

18.81

1.4

1.3

692.70

2505.97

e6/l

1.08

Ischaemic Stroke, excluding all haemorrhages

548

2683

1.53

18.74

1.4

1.5

1786.62

2984.76

e6/l

1.61

405

1936

Myocarditis

4.89

18.73

1.4

1.2

2783.81

3407.27

e6/l

0.15

Mycoses

225

1183

1.92

18.61

1.5

3436.86

2267.62

e6/l

0.33

161

850

Malignant neoplasm of breast, HER-negative

111

431

2.55

18.55

1.4

3021.99

2914.88

e6/l

0.03

314

Fracture of rib(s), sternum and thoracic spine

285

1616

1.78

18.50

1.5

4132.81

2528.24

e6/l

0.56

209

1176

Unspecified privation

108

425

2.58

18.42

1.7

1.4

2639.85

1931.16

e6/l

0.43

315

Hepatic failure, not elsewhere classified

147

3.85

18.26

1.8

1.3

1541.63

1789.34

e6/l

0.17

105

Other diseases of intestines

716

2812

1.45

18.25

1.5

1.4

2508.50

3833.59

e6/l

1.45

521

2043

Malignant neoplasm of oesophagus, including Hilmo

125

4.11

18.19

1.4

1.5

2011.44

1894.38

e6/l

0.06

Non-follicular lymphoma

118

488

2.46

18.19

1.6

1.5

1981.90

1771.47

e6/l

0.25

351

Cytomegalovirus infection, IBD co-morbidity

5.88

18.17

1.4

1.3

692.70

2848.92

e6/l

1.37

Persons encountering health services for specific procedures, not carried out

199

3.36

18.16

1.6

1.3

24228.06

2726.93

e6/l

0.54

142

Other viral hepatitis

112

4.25

18.11

1.6

1.3

31586.75

2458.67

e6/l

0.73

Open wound of lower leg

133

580

2.32

18.09

1.5

2507.03

2471.29

e6/l

0.02

100

432

Malignant neoplasm of other and ill-defined sites, including Hilmo

6.72

18.07

1.4

1.3

1226.27

2123.94

e6/l

0.72

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

167

3.62

17.98

1.7

1.5

973.05

1737.74

e6/l

1.31

119

Hypertrophic cardiomyopathy

182

3.50

17.93

1.8

1.4

686.15

1683.61

e6/l

3.66

129

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

123

504

2.39

17.81

1.7

1.5

1902.14

2552.26

e6/l

0.59

360

Malignant neoplasm of head and neck

291

2.90

17.72

1.4

1.5

2811.91

1805.56

e6/l

0.39

209

Small cell lung cancer

4.71

17.64

1.3

1.5

4133.19

1291.73

e6/l

1.38

Small cell lung cancer, including Hilmo

4.71

17.64

1.3

1.5

4133.19

1291.73

e6/l

1.38

Amyloidosis, other/unspecified

4.93

17.50

1.5

1.3

655.54

1322.26

e6/l

1.50

Diseases of the skin and subcutaneous tissue

717

2494

1.45

17.45

1.5

1.4

2527.10

2915.02

e6/l

0.40

513

1827

Acute bronchitis

344

2045

1.66

17.39

1.5

3361.25

2545.36

e6/l

0.30

258

1480

Malignant neoplasm, without specification of site

125

4.03

17.37

1.4

1.5

1378.30

1385.57

e6/l

0.01

Symptoms and signs involving cognition, perception, emotional state and behaviour

702

3350

1.43

17.25

1.4

1.5

4541.26

2917.95

e6/l

0.54

514

2419

Aortic valve malfunction, age under 60 years

303

2.81

17.03

1.5

7004.88

2733.42

e6/l

0.43

219

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

127

540

2.30

16.98

1.7

1.5

1885.60

2474.08

e6/l

0.55

388

Other symptoms and signs involving the circulatory and respiratory systems

183

3.38

16.96

1.6

1.3

3395.76

1978.67

e6/l

0.66

129

L02BA Anti-estrogens

118

504

2.36

16.85

1.4

1495.55

2406.27

e6/l

1.27

367

Chronic ulcer of skin, not elsewhere classified

328

2.74

16.83

1.6

1.4

2078.48

1769.64

e6/l

0.11

236

Pleural plaque with presence of asbestos

119

515

2.37

16.70

1.4

1.5

1941.74

2069.76

e6/l

0.08

105

361

Medical observation and evaluation for suspected diseases and conditions

482

1591

1.55

16.67

1.5

1.4

2350.15

2514.21

e6/l

0.15

388

1086

Diabetic retinopathy

325

1202

1.70

16.59

1.5

4009.70

2424.00

e6/l

0.24

243

853

Other or unspecified ileus, impaction or obstruction

194

1011

1.94

16.56

1.5

1323.53

2352.91

e6/l

2.05

135

727

Myelodysplastic syndrome, including Hilmo

112

4.14

16.52

1.5

993.57

1624.06

e6/l

0.94

Secondary right heart disease

213

3.19

16.44

1.5

1.4

1008.33

1490.26

e6/l

1.06

155

Lymphoid leukaemia

255

2.97

16.41

1.7

1.4

5210.93

1670.64

e6/l

0.88

183

Other and unspecified polyneuropathies, also in other diseases

197

1038

1.92

16.33

1.6

1.5

1632.88

2270.53

e6/l

0.72

141

755

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

103

421

2.48

16.30

1.6

1.4

3845.97

1981.81

e6/l

0.58

298

Immunodeficiency with predominantly antibody defects

5.58

16.26

1.6

1.3

1888.28

1905.00

e6/l

0.01

Medicines for HER+ breast cancer

234

1230

1.81

16.24

1.4

4023.76

2954.77

e6/l

0.16

172

888

L04AX Other immunosuppressants

379

2396

1.59

16.21

1.5

3070.96

3397.62

e6/l

0.18

263

1733

Hodgkin lymphoma, hilmo

4.65

16.20

1.9

1.3

1500.10

1747.21

e6/l

0.21

Retention of urine

361

1843

1.62

16.15

1.6

1.5

5322.18

2841.25

e6/l

0.59

254

1363

Sequelae with surgical and medical care as external cause

184

952

1.95

16.08

1.6

1.5

1978.85

2138.94

e6/l

0.13

125

684

Other disorders of skin and subcutaneous tissue, not elsewhere classified

138

643

2.17

16.06

1.5

4477.94

2138.76

e6/l

0.47

108

476

Colorectal cancer

184

930

1.95

16.04

1.5

1.4

1040.36

2536.32

e6/l

2.78

139

684

Artificial opening status

221

3.10

16.04

1.6

1.3

4870.76

1792.27

e6/l

0.51

154

Drug-induced neutropenia

280

2.84

16.03

1.5

1.4

2466.16

1962.41

e6/l

0.32

196

Injuries to the abdomen, lower back, lumbar spine and pelvis

326

1973

1.64

16.00

1.6

1.5

6168.96

2608.86

e6/l

0.64

248

1414

Injuries to the hip and thigh

427

2515

1.55

15.96

1.5

3719.34

2608.55

e6/l

0.21

306

1822

Other (not insulin) diabetes medications

690

2890

1.42

15.85

1.5

1.4

2802.81

3733.62

e6/l

0.59

485

2114

Congenital malformations of heart and great arteries

367

2.53

15.71

1.7

1.5

2359.82

2139.77

e6/l

0.14

265

Hernia

669

3167

1.42

15.68

1.5

2124.22

3523.47

e6/l

1.97

467

2308

Type 2 diabetes, definitions combined, including avohilmo

649

2645

1.43

15.59

1.5

1.4

3082.70

3521.62

e6/l

0.23

451

1937

Asthma and allergy

5.29

15.57

1.8

1.2

3118.73

1902.24

e6/l

0.38

Other or ill-defined heart diseases

4.19

15.56

1.4

1.2

1598.04

2593.38

e6/l

0.65

Malignant neoplasm of colon, including Hilmo

153

752

2.05

15.43

1.4

1.5

1143.17

2720.53

e6/l

2.21

118

554

Constipation

682

3359

1.41

15.43

1.5

3251.57

3178.44

e6/l

0.03

502

2443

Second line medication for Crohn's disease

382

2450

1.57

15.38

1.5

3068.86

3578.94

e6/l

0.29

265

1770

Purpura and other haemorrhagic conditions

127

585

2.20

15.25

1.5

2281.76

2328.11

e6/l

0.02

104

424

Emphysema

363

2.55

15.22

1.3

1.4

3504.39

1612.74

e6/l

1.05

256

Disorders of thyroid, IBD co-morbidities

120

368

2.31

15.15

1.6

1.4

2096.17

3617.10

e6/l

0.38

252

Other pulmonary heart/vessel disease

235

2.97

15.07

1.4

1102.11

1547.48

e6/l

0.92

172

Immunodeficiencies

134

3.65

14.96

1.7

1.3

1910.35

1712.35

e6/l

0.14

Diverticular disease of intestine

581

2574

1.45

14.94

1.5

1.4

2609.62

3520.31

e6/l

0.68

409

1881

Intracranial trauma

385

1731

1.57

14.87

1.5

1.4

3694.61

2982.64

e6/l

0.25

284

1207

Malignant neoplasm of other connective and soft tissue, including Hilmo

121

3.80

14.82

1.4

1.5

1010.30

1832.19

e6/l

1.80

Rare circulating lymphoid malignancy, including Hilmo

4.50

14.79

1.6

1.5

8791.14

2526.91

e6/l

0.67

Malignant melanoma, including Hilmo

131

620

2.13

14.67

1.6

1.5

1650.54

2597.84

e6/l

0.99

453

Falls/tendency to fall

714

2561

1.40

14.63

1.5

1.4

2364.91

2923.23

e6/l

0.40

512

1862

Abnormal results of function studies

266

2.78

14.58

1.5

1.4

1895.80

1826.81

e6/l

0.06

189

Exposure to unspecified factor

685

3553

1.39

14.48

1.5

1.4

4081.09

3189.72

e6/l

0.23

457

2614

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

4.06

14.25

1.4

12102.11

2507.70

e6/l

0.74

Gastrointestinal diseases

334

1028

1.63

14.19

1.5

1.4

2524.50

4260.93

e6/l

1.22

238

758

Malignant melanoma

110

493

2.25

14.14

1.6

1.5

1711.10

2962.98

e6/l

1.12

362

Persons encountering health services in other circumstances, wide

840

3205

1.35

14.08

1.6

1.4

3903.50

3165.53

e6/l

0.25

579

2355

ILD medications: azathioprine

420

2.35

13.97

1.6

1.4

2596.36

2396.61

e6/l

0.11

305

Viral hepatitis

165

3.25

13.95

1.5

1.4

28928.34

2164.66

e6/l

0.74

114

Malignant neoplasm of oral cavity, including Hilmo

131

3.58

13.94

1.5

2897.28

1674.01

e6/l

0.23

Haemorrhage, not elsewhere classified

176

3.20

13.93

1.4

1.3

1006.23

1679.61

e6/l

1.82

129

Bronchiectasis

361

2.48

13.91

1.4

2157.18

2073.21

e6/l

0.05

258

Biguanides

682

3008

1.39

13.74

1.5

1.4

2825.70

3626.94

e6/l

0.48

479

2198

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

388

2.41

13.70

1.8

1.4

2972.63

1867.44

e6/l

0.33

290

Certain disorders involving the immune mechanism

149

759

1.98

13.70

1.7

1.5

1889.94

2406.24

e6/l

0.78

110

552

Benzodiazepine use

707

3557

1.37

13.69

1.5

4853.36

2978.12

e6/l

0.69

523

2577

Other special examinations and investigations of persons without complaint or reported diagnosis

468

1591

1.49

13.60

1.6

1.4

2389.48

2514.21

e6/l

0.10

360

1086

284

1738

1.63

13.55

1.4

1.5

2353.64

2694.67

e6/l

0.31

210

1256

Unstable angina pectoris

336

1693

1.58

13.44

1.5

2036.28

3657.92

e6/l

1.18

241

1239

Viral pneumonia (unknown virus, not influenza)

222

2.88

13.44

1.7

1.4

1866.02

1725.46

e6/l

0.13

160

Systemic lupus erythematosus

4.33

13.41

1.5

1.3

4306.57

1628.13

e6/l

0.96

Fracture of lumbar spine and pelvis

207

1178

1.77

13.38

1.6

1.5

7360.14

2620.21

e6/l

0.54

160

848

Congenital malformations of cardiac septa

139

3.38

13.36

2.1

1.4

2105.30

1851.70

e6/l

0.10

L02BG Aromatase inhibitors

197

1105

1.79

13.34

1.4

4495.29

3087.64

e6/l

0.18

142

803

Congenital malformations of the circulatory system

101

434

2.28

13.29

1.8

1.4

2281.12

2364.82

e6/l

0.05

312

Injury of other and unspecified intrathoracic organs

264

2.70

13.17

1.4

2165.04

1521.51

e6/l

0.85

194

Status post-ami

267

1235

1.66

13.14

1.5

2488.06

2674.10

e6/l

0.05

207

903

Diabetic retinopathy, strict definition

163

763

1.91

13.11

1.6

1.5

1352.92

2863.22

e6/l

1.15

120

525

383

2.37

13.07

1.6

1.4

6552.33

2257.85

e6/l

0.43

285

Asthma and opportunity respiratory infection

221

2.87

13.04

1.4

2458.55

1651.57

e6/l

0.60

162

Reimbursement for rheumatic diseases

390

2599

1.50

13.01

1.5

2969.26

3174.63

e6/l

0.11

273

1885

SLE (Finngen)

4.23

13.00

1.5

1.3

4306.57

2254.08

e6/l

0.65

Cutaneous abscess, furuncle and carbuncle

183

1015

1.81

12.95

1.7

1.5

2884.05

2266.76

e6/l

0.18

138

737

SLE, strict definition

4.41

12.91

1.6

1.3

4466.82

1749.29

e6/l

0.93

SLE, ICD10

4.41

12.91

1.6

1.3

4466.82

1749.29

e6/l

0.93

Osteoporosis

224

1229

1.72

12.91

1.5

1.4

2677.91

2453.24

e6/l

0.11

172

879

Sulfasalazine

189

1060

1.79

12.88

1.5

1.4

3094.77

2956.17

e6/l

0.05

127

751

Systemic lupus erythematosus, unspecified

4.77

12.88

1.6

1.2

4583.62

1721.05

e6/l

0.93

Other other unspecified disorders of the circulatory system

149

3.30

12.80

1.8

1.3

1504.26

1746.04

e6/l

0.23

104

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

4.27

12.77

1.8

1.3

1374.64

2287.63

e6/l

0.84

Hydronephrosis

105

483

2.20

12.74

1.5

1.4

946.30

1872.41

e6/l

3.74

364

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

116

554

2.11

12.69

1.5

1001.29

2708.44

e6/l

1.67

404

Other diseases of intestine

136

691

1.99

12.66

1.5

1903.28

2232.00

e6/l

0.27

493

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

4.98

12.65

1.4

954.57

2175.66

e6/l

1.27

Morphin

4.26

12.61

1.8

1.5

1156.19

1165.34

e6/l

0.01

Squamous cell neoplasms and carcinomas of the skin

360

2.39

12.53

1.5

1125.02

2071.48

e6/l

0.81

263

Abnormal findings on diagnostic imaging of other body structures

104

481

2.18

12.44

1.8

1.4

1863.99

1784.29

e6/l

0.05

346

Vascular disorders of the intestines

350

2.41

12.40

1.5

1.4

1704.75

1719.78

e6/l

0.01

254

Systemic connective tissue disorders

262

1624

1.62

12.37

1.5

2162.97

2624.10

e6/l

0.37

174

1179

Other external causes of accidental injury

556

1970

1.42

12.35

1.6

1.4

2085.38

2797.28

e6/l

1.21

404

1435

Acute pancreatitis

171

944

1.83

12.35

1.5

7395.41

2326.40

e6/l

0.46

126

689

Angina pectoris

431

1961

1.47

12.29

1.6

1.5

2179.28

3847.36

e6/l

1.46

315

1423

Other gastritis (incl. Duodenitis)

196

1129

1.75

12.26

1.6

1.5

2420.16

2539.72

e6/l

0.05

135

810

Azathioprine

445

2.22

12.25

1.6

1.4

2596.36

2422.04

e6/l

0.10

322

Malignant neoplasm of oral cavity

3.87

12.22

1.5

692.73

1771.82

e6/l

2.44

Tobacco use

148

3.22

12.21

1.5

1.4

2188.23

1794.18

e6/l

0.17

101

Abdominal and pelvic pain

685

2527

1.37

12.20

1.5

2900.21

3610.79

e6/l

0.51

505

1837

Open wound of head

420

2794

1.45

11.98

1.5

4085.41

2832.03

e6/l

0.37

311

2028

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

200

1167

1.73

11.95

1.5

3729.91

2537.07

e6/l

0.57

146

835

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

314

2.46

11.88

1.5

1.4

3473.32

1762.69

e6/l

0.42

226

Other disorders of white blood cells

221

2.76

11.87

1.6

1.4

3045.21

1953.49

e6/l

0.69

155

Vitreous haemorrhage

452

2.20

11.86

1.5

2043.67

2160.92

e6/l

0.04

331

Left bundle-branch block

199

2.85

11.80

1.4

1.3

1033.00

2523.19

e6/l

2.46

139

Malignant neoplasm of oesophagus

3.92

11.72

1.3

1.6

1172.84

1975.61

e6/l

0.96

Atrial septal defect

4.17

11.69

2.1

1.3

1520.30

1851.06

e6/l

0.22

Other embolism and thrombosis

120

601

2.02

11.68

1.5

8613.88

2488.59

e6/l

0.41

444

Colorectal adenocarcinoma

149

800

1.87

11.68

1.4

1.5

1086.50

2643.23

e6/l

2.33

110

585

Accidents

551

1970

1.40

11.67

1.6

1.4

2089.72

2797.28

e6/l

1.19

403

1435

Seropositive rheumatoid arthritis, wide

206

1221

1.70

11.63

1.5

3654.55

2606.67

e6/l

0.50

151

875

Malignant neoplasm of tongue, including Hilmo

4.27

11.59

1.6

1.4

3906.60

2112.04

e6/l

0.23

Seropositive rheumatoid arthritis

206

1218

1.70

11.57

1.5

1.4

3654.55

2846.25

e6/l

0.34

151

865

Fracture of lower leg, including ankle

374

2518

1.48

11.57

1.5

4259.03

3552.05

e6/l

0.15

259

1820

Other infectious diseases

412

2.24

11.55

1.6

1.4

2449.85

1844.88

e6/l

0.26

303

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

133

689

1.93

11.53

1.4

1.5

8488.85

2432.31

e6/l

0.95

103

490

Primary biliary cholangitis (PBC)

5.12

11.52

1.4

1.2

1691.75

1864.48

e6/l

0.09

Candidiasis

105

503

2.11

11.52

1.6

1.4

5303.30

1988.62

e6/l

0.50

372

Systemic sclerosis

4.75

11.47

1.7

1.3

2539.63

1734.22

e6/l

0.35

Benign neoplasms

659

2687

1.36

11.46

1.5

1.4

2407.10

3939.50

e6/l

1.66

484

1959

Thyrotoxicosis, other and/or unspecified

132

688

1.93

11.42

1.6

1.5

1838.31

3127.88

e6/l

0.67

500

Malignant neoplasm of colon

116

579

2.02

11.39

1.5

1152.68

3107.64

e6/l

2.02

419

Multiple myeloma, including Hilmo

160

3.06

11.39

1.2

1.5

976.65

1695.91

e6/l

1.46

113

Problems related to lifestyle

297

2.45

11.27

1.5

1.4

3100.96

2526.98

e6/l

0.24

216

Dermatitis

429

3000

1.43

11.26

1.5

1.4

4273.25

3015.16

e6/l

0.38

315

2163

Late syphilis

5.73

11.26

1.6

1.4

6843.18

1412.87

e6/l

0.40

Other disorders involving the immune mechanism, not elsewhere classified

3.87

11.25

1.8

1.3

1374.64

2133.91

e6/l

0.70

Diarrhoea and gastroenteritis of presumed infectious origin

680

3359

1.34

11.23

1.5

2243.32

3502.61

e6/l

1.74

498

2422

Disease of hard tissues of teeth, NOS

207

1782

0.61

11.15

1.6

1.5

3156.01

2636.29

e6/l

0.27

142

1294

Rheumatoid arthritis, including avohilmo

278

1793

1.56

11.14

1.5

3640.83

2511.55

e6/l

0.72

206

1288

Superficial injury of head

180

1041

1.74

11.12

1.5

7760.48

2376.20

e6/l

0.56

139

743

Conotruncal defects

14.31

11.04

1.6

1.5

4770.17

2411.13

e6/l

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

196

2.82

11.04

1.5

1.4

1909.64

1651.39

e6/l

0.24

142

Persons encountering health services for other counselling and medical advice, not elsewhere classified

764

3157

1.32

11.03

1.6

1.4

3663.72

3194.32

e6/l

0.14

528

2319

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

4.78

11.02

1.2

1.3

919.57

1889.03

e6/l

0.92

Rheumatoid arthritis

262

1495

1.58

10.99

1.5

1.4

3621.24

2921.47

e6/l

0.33

192

1077

Candidiasis

178

1031

1.74

10.94

1.6

1.5

5211.70

2728.91

e6/l

0.49

135

753

Other interstitial pulmonary diseases

160

901

1.80

10.93

1.6

1.5

4665.16

1953.29

e6/l

0.58

107

658

Thyrotoxicosis

164

931

1.77

10.83

1.5

1783.18

2967.44

e6/l

0.86

119

671

Elevated blood glucose level

322

2.36

10.80

1.6

1.4

1296.40

1663.01

e6/l

0.62

238

Other/unspecified seropositive rheumatoid arthritis

200

1202

1.67

10.76

1.5

3729.91

2615.31

e6/l

0.52

146

861

Systemic sclerosis, icd10

4.65

10.76

1.7

1.2

2701.60

1573.65

e6/l

0.50

Mental and behavioural disorders due to opioids

4.95

10.75

1.8

1.2

3510.56

2276.27

e6/l

0.41

Interstitial lung disease endpoints

160

906

1.79

10.74

1.6

1.5

4665.16

1951.63

e6/l

0.58

107

659

Interstitial lung disease

160

906

1.79

10.74

1.6

1.5

4665.16

1951.63

e6/l

0.58

107

659

Chronic gastritis

241

1520

1.60

10.69

1.5

1.4

7918.44

2323.21

e6/l

0.76

172

1093

Other infectious diseases

349

2.30

10.67

1.7

1.4

2716.32

1858.61

e6/l

0.32

253

ILD, hospital admissions

156

879

1.79

10.65

1.6

1.5

4767.19

1984.59

e6/l

0.58

104

640

In situ neoplasms

301

2001

1.51

10.54

1.5

3127.78

2564.04

e6/l

0.15

193

1465

Injury, poisoning and certain other consequences of external causes

351

1178

1.50

10.46

1.5

1.4

2074.66

2453.71

e6/l

0.53

258

842

Malignant neoplasm of pancreas, including Hilmo

303

2.37

10.38

1.2

1.5

2500.65

1458.47

e6/l

0.73

221

Chronic nephritic syndrome

137

3.12

10.37

1.7

1.4

651.65

1713.02

e6/l

3.39

Malignant neoplasm of pancreas

237

2.57

10.36

1.2

1.5

2645.47

1508.63

e6/l

0.68

175

Dysphagia

202

1230

1.65

10.36

1.5

1699.92

2318.63

e6/l

0.51

142

877

Persons encountering health services for examination and investigation

450

1591

1.42

10.30

1.5

1.4

2944.70

2514.21

e6/l

0.37

343

1086

Malignant melanoma of skin, including Hilmo

101

499

2.04

10.25

1.6

1.5

1648.99

2859.15

e6/l

1.08

370

Weight loss

447

2.11

10.20

1.5

1.4

2769.37

1819.87

e6/l

0.51

322

Diagnoses used for exclusion with ILD

220

1374

1.61

10.20

1.5

1819.14

2208.26

e6/l

0.56

161

989

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

4.42

10.11

1.6

1.3

4708.44

2289.65

e6/l

0.25

Disorders of mineral metabolism

313

2.33

10.10

1.5

1.4

1343.84

2251.77

e6/l

0.93

228

Acute pancreatitis (for exclusion)

171

1004

1.72

10.09

1.5

7395.41

2156.63

e6/l

0.48

126

732

Unspecified fall

367

2521

1.44

10.06

1.5

4779.84

2646.90

e6/l

0.39

263

1814

Small cell lung cancer, helper endpoint

135

3.12

10.03

1.3

1.4

4133.19

1447.68

e6/l

1.29

Covid-19 suspected case

116

608

1.92

9.93

1.6

1.5

5787.80

2397.85

e6/l

0.47

446

Congenital malformations, deformations and chromosomal abnormalities

299

1910

1.49

9.92

1.6

1.5

4096.63

3265.78

e6/l

0.16

224

1364

Malignant neoplasm of other connective and soft tissue

3.98

9.91

1.3

1.4

888.61

2030.81

e6/l

1.67

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

208

1294

1.62

9.79

1.5

1844.58

2919.61

e6/l

1.12

151

939

Adenocarcinoma and ductal carcinoma of pancreas

121

3.21

9.79

1.2

1.5

2718.07

1719.38

e6/l

0.37

Cholelithiasis, broad definition with cholecystitis

618

3142

1.33

9.79

1.4

1.5

3494.01

2857.13

e6/l

0.17

449

2289

Benign neoplasm: Transverse colon

106

545

1.97

9.69

1.4

1.5

2909.48

1821.29

e6/l

0.50

394

Benign neoplasm: Colon, unspecified

228

1458

1.58

9.61

1.5

1355.07

2312.26

e6/l

2.59

162

1062

Pulmonary oedema

3.64

9.59

1.6

1.3

607.64

1440.26

e6/l

1.82

Other antidepressants

733

2895

1.30

9.55

1.5

4298.55

2523.20

e6/l

0.71

532

2109

Other and unspecified disorders of white blood cells

166

2.82

9.54

1.6

1.3

1882.50

1599.33

e6/l

0.19

120

Fracture of shoulder and upper arm

262

1729

1.52

9.49

1.5

5456.85

2637.47

e6/l

0.38

197

1235

Viral infections characterized by skin and mucous membrane lesions

271

1802

1.51

9.47

1.5

4616.63

3207.89

e6/l

0.36

190

1309

Poisoning by drugs, medicaments and biological substances

123

668

1.85

9.46

1.4

8676.70

2497.02

e6/l

0.83

493

Cholecystitis

132

734

1.81

9.45

1.4

1.5

7970.37

2241.41

e6/l

0.40

531

Vascular diseases of the intestine

184

2.72

9.43

1.3

1.4

2125.74

1776.92

e6/l

0.16

134

Amputation of ankle bones

109

3.31

9.40

1.5

1.4

675.39

1701.94

e6/l

2.33

Chronic periodontitis, complicated

394

2794

1.40

9.38

1.5

3699.00

3339.23

e6/l

0.18

259

2065

Late syphilis

4.62

9.37

1.6

1.4

6291.33

2036.13

e6/l

0.33

Acute posthaemorrhagic anaemia

146

2.93

9.33

1.1

1.4

1545.34

1322.17

e6/l

0.22

103

Autoimmune diseases related-to ILD

549

3531

1.33

9.33

1.5

5210.60

2956.80

e6/l

0.63

397

2569

Delirium, not induced by alcohol and other psychoactive substances

130

722

1.82

9.32

1.5

5260.71

1495.67

e6/l

1.00

533

General examination and investigation of persons without complaint and reported diagnosis

425

1581

1.41

9.29

1.5

1.4

3655.74

2527.42

e6/l

0.56

349

1078

Aortic aneurysm

231

1465

1.56

9.28

1.4

1.5

2393.93

2388.89

e6/l

0.00

160

1088

External causes of morbidity and mortality

417

1484

1.41

9.22

1.5

1.4

2194.33

2555.63

e6/l

0.51

308

1066

Other viral diseases

151

876

1.73

9.20

1.5

2713.74

2495.28

e6/l

0.11

101

632

Injury of intra-abdominal organs

4.48

9.11

1.3

3271.27

1915.89

e6/l

0.47

Sequelae of cerebrovascular disease

338

2036

1.44

9.11

1.4

1.5

1782.24

2516.67

e6/l

0.75

256

1483

Other specified/unspecified systemic involvement of connective tissue

170

2.74

9.10

1.3

4620.46

2524.25

e6/l

0.49

114

Sulfonylureas

355

1988

1.43

9.10

1.6

1.5

1747.26

2535.33

e6/l

0.76

265

1468

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

176

2.71

9.09

1.5

1221.24

1476.20

e6/l

0.18

123

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

322

2.23

9.05

1.5

1.4

1073.68

1883.22

e6/l

1.98

232

Volvulus

117

3.15

9.00

1.3

4502.03

1140.04

e6/l

0.61

Duodenal ulcer

113

609

1.88

8.99

1.4

9088.22

1989.69

e6/l

0.47

445

Other arthritis (FG)

216

1386

1.57

8.97

1.5

1.4

3496.80

3130.59

e6/l

0.13

158

994

Septal defects

135

2.93

8.94

2.0

1.4

1673.12

2083.84

e6/l

0.26

Other and unspecified local infections of skin and subcutaneous tissue

363

2.14

8.93

1.7

1.4

2064.75

2003.99

e6/l

0.03

273

Other noninfective gastroenteritis and colitis

171

1038

1.66

8.92

1.4

1.5

3560.72

2172.31

e6/l

0.53

116

756

Pain (limb, back, neck, head abdominally)

519

1927

1.35

8.90

1.5

2687.27

3363.83

e6/l

0.43

371

1398

Any mental disorder

743

2901

1.29

8.87

1.5

6095.44

2096.13

e6/l

1.83

555

2079

Phlebitis and thrombophlebitis (not including DVT)

168

1018

1.66

8.86

1.5

2656.43

3179.69

e6/l

0.23

120

735

Diabetic maculopathy

110

555

1.89

8.84

1.6

1.5

985.23

2626.05

e6/l

3.39

385

Other nutritional deficiencies

372

2506

1.40

8.81

1.5

5509.83

3226.29

e6/l

0.41

276

1803

Malignant neoplasm of stomach, including Hilmo

214

2.51

8.80

1.3

1.5

1224.77

1363.57

e6/l

0.18

152

Seropositive rheumatoid arthritis, strict definition

110

592

1.87

8.78

1.5

4432.55

1833.01

e6/l

1.03

431

Obesity related asthma

219

1417

1.55

8.78

1.6

1.5

2153.75

2845.53

e6/l

0.62

157

1031

Failure and rejection of transplanted organs and tissues

7.86

8.72

1.3

9134.85

4268.47

e6/l

0.27

Other viral diseases

178

1090

1.63

8.69

1.4

1.5

2644.58

2519.26

e6/l

0.07

118

798

Other renal tubulo-interstitial diseases

4.31

8.69

1.4

1.2

1809.00

1580.10

e6/l

0.10

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

240

2.41

8.66

1.6

1.5

1104.73

1492.30

e6/l

0.37

173

Fitting and adjustment of other devices

262

1590

1.49

8.66

1.4

1740.09

2793.08

e6/l

1.11

226

1166

Mixed connective tissue disease

198

2.56

8.65

1.4

1.3

4221.48

2472.46

e6/l

0.49

138

Other complications of surgical and medical care, not elsewhere classified

342

2.15

8.61

1.5

1.4

1646.85

2548.25

e6/l

0.76

248

Osteonecrosis

241

2.40

8.60

1.3

1.4

3963.68

1756.47

e6/l

0.79

173

Drug-induced hypoglycaemia without coma

4.15

8.59

1.5

1.2

5617.06

2134.66

e6/l

0.40

Chronic apical periodontitis

740

3309

1.28

8.59

1.5

4123.50

3104.35

e6/l

0.31

524

2407

Diseases of the myoneural junction and muscle

108

584

1.87

8.52

1.5

18524.67

1971.56

e6/l

1.16

420

Acidosis

3.75

8.51

1.6

1.4

2369.11

1285.79

e6/l

0.27

Discitis, unspecified

3.99

8.49

1.5

1.3

50855.64

1306.02

e6/l

0.50

Dizziness and giddiness

526

3159

1.32

8.45

1.4

1.5

2077.53

2795.05

e6/l

1.03

398

2293

Malignant neoplasm of tongue

4.39

8.45

1.6

1.4

690.23

2045.08

e6/l

1.60

Malignant neoplasm of stomach

183

2.60

8.43

1.3

1.5

1290.26

1482.52

e6/l

0.22

130

Congenital malformations of aortic and mitral valves

111

3.11

8.42

1.5

2466.61

1819.54

e6/l

0.40

DVT of lower extremities

161

979

1.66

8.42

1.4

1.5

2131.26

3126.25

e6/l

0.48

112

704

Postmenopausal atrophic vaginitis

664

0.44

8.39

1.3

1.4

1967.17

3674.15

e6/l

0.73

473

Complications of internal orthopaedic prosthetic devices, implants and grafts

185

1166

1.60

8.37

1.4

2107.32

2895.73

e6/l

0.55

114

844

Systemic sclerosis (FG)

3.69

8.33

1.7

1.3

2539.63

2170.73

e6/l

0.13

Lung diseases due to external agents

139

816

1.72

8.32

1.4

1.5

1540.14

1961.91

e6/l

0.56

105

588

Other diseases of arteries and capillaries

374

2.08

8.30

1.6

1.4

969.23

2724.02

e6/l

3.00

276

Other and unspecified dermatitis

341

2435

1.41

8.29

1.5

4958.55

3189.72

e6/l

0.45

253

1740

Syphilis

3.58

8.29

1.6

1.4

5232.18

2112.02

e6/l

0.36

Syphilis

3.58

8.29

1.6

1.4

5232.18

2112.02

e6/l

0.36

Infection of intervertebral disc (pyogenic)

4.35

8.28

1.9

1.4

2574.75

1355.03

e6/l

0.40

Chronic periodontitis, including avohilmo

646

3371

1.29

8.27

1.5

4331.84

3009.13

e6/l

0.58

448

2468

Mental and behavioural disorders due to use of other stimulants, including caffeine

7.13

8.27

1.6

1.3

54577.92

2444.81

e6/l

0.48

Acquired haemolytic anaemia

3.34

8.26

1.7

1.3

784.86

1607.57

e6/l

1.23

Arthropathies in other diseases classified elsewhere

134

2.89

8.26

1.6

1.3

4150.31

1588.82

e6/l

0.47

Shock, not elsewhere classified

4.71

8.21

1.5

1.3

1106.92

1766.70

e6/l

0.49

Alcohol dependence

199

1281

1.56

8.21

1.6

1.5

9082.34

2403.94

e6/l

0.78

147

912

Pneumocystosis

3.67

8.20

1.7

1.3

2667.10

1401.73

e6/l

0.66

Concussion

303

1724

1.44

8.18

1.5

1.4

4231.37

2993.69

e6/l

0.41

235

1201

Other/unspecified rheumatoid arthritis

104

565

1.86

8.11

1.5

3662.23

2255.43

e6/l

0.52

413

Periodontitis

647

3379

1.28

8.10

1.5

4330.49

3003.01

e6/l

0.58

449

2472

Genitourinary diseases

368

1314

1.41

8.10

1.5

1.4

2052.61

4630.91

e6/l

1.91

259

951

Injuries to the knee and lower leg

772

3407

1.26

8.07

1.5

2898.07

3389.72

e6/l

0.22

553

2474

Attention to artificial openings

147

2.76

8.06

1.3

4427.59

2092.45

e6/l

0.49

106

Diaphragmatic hernia

276

1910

1.45

8.03

1.5

2684.05

2657.89

e6/l

0.01

187

1372

Benign neoplasm: Ascending colon

126

729

1.74

7.98

1.8

1.5

2507.32

2042.07

e6/l

0.20

534

Suicide or other Intentional self-harm

129

750

1.73

7.97

1.4

8386.41

2501.68

e6/l

0.87

100

547

Unspecified misadventure during surgical and medical care

207

2.45

7.93

1.7

1.4

1004.56

1766.37

e6/l

2.10

150

Mycoses

533

3558

1.31

7.92

1.5

3146.47

3435.85

e6/l

0.11

367

2595

Dentofacial anomalies [including malocclusion]

153

1975

0.62

7.91

1.6

1.4

3942.47

3443.75

e6/l

0.16

111

1420

Intracranial injury

400

2792

1.36

7.91

1.5

3375.89

2737.24

e6/l

0.25

301

2025

ILD, hospital admissions 1, main diag only

134

791

1.71

7.91

1.6

1.5

5498.08

1850.08

e6/l

0.65

575

Other diseases of pancreas

375

2.05

7.89

1.5

1.4

1942.16

1851.37

e6/l

0.07

270

Disorders of calcium metabolism

251

2.30

7.87

1.5

1.4

1536.69

2290.99

e6/l

0.56

184

Colon adenocarcinoma

458

1.94

7.83

1.4

1.5

1239.02

2926.32

e6/l

1.73

332

Congenital malformations, deformations and chromosomal abnormalities

323

2123

1.40

7.82

1.6

1.5

4354.26

3177.18

e6/l

0.25

240

1519

ILD-related respiratory insufficiency

179

2.57

7.81

1.4

9331.32

1490.16

e6/l

0.53

128

Malignant neoplasm of larynx

4.28

7.79

1.4

1.5

6532.14

2301.64

e6/l

0.47

Myelodysplastic syndrome

4.66

7.72

1.4

1.5

663.42

1949.52

e6/l

1.07

Neurological diseases, wide definition

142

414

1.73

7.70

1.5

1.4

2373.21

3751.75

e6/l

0.39

285

Congenital malformations of the urinary system

168

2.59

7.69

1.7

1.3

901.58

2085.25

e6/l

1.76

115

Other local infections of skin and subcutaneous tissue

399

2.00

7.68

1.7

1.4

2001.69

1936.83

e6/l

0.04

296

Thoracic aortic aneurysm

127

746

1.72

7.64

1.3

1.5

3320.88

2540.38

e6/l

0.29

542

Disorder of lipoprotein metabolism, unspecified

118

679

1.75

7.63

1.5

1412.41

2082.74

e6/l

0.96

499

Abnormal weight loss

414

1.98

7.63

1.5

1.4

1801.93

1846.03

e6/l

0.04

295

Thrombocytopenia, unspecified

300

2.16

7.61

1.5

1.4

1195.23

1619.36

e6/l

0.79

212

Thyrotoxicosis with toxic multinodular goitre

255

2.27

7.61

1.8

1.4

1637.49

1654.79

e6/l

0.02

183

Restrictive cardiomyopathy

9.29

7.57

2.0

1.3

464.80

1045.31

e6/l

—

Malignant melanoma of skin

367

2.03

7.56

1.6

1.5

1725.53

2855.70

e6/l

0.77

270

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

133

792

1.69

7.55

1.4

8488.85

2641.63

e6/l

0.90

103

576

Other (seronegative) rheumatoid arthritis, wide

138

832

1.67

7.51

1.5

4339.49

2000.59

e6/l

1.08

104

606

Retinal vascular disorders

117

676

1.75

7.48

1.4

1.5

1145.02

1817.93

e6/l

2.08

487

Need for immunization against other single viral diseases

3.98

7.47

1.7

1.4

966.77

1918.08

e6/l

1.12

Other and unspecified vascular occlusions

509

1.87

7.46

1.5

1263.61

1965.82

e6/l

1.53

369

Pyogenic arthritis

309

2.13

7.46

1.5

1.4

1863.16

1744.79

e6/l

0.07

227

Exposure to other specified factors

442

3070

1.32

7.38

1.5

7563.58

2810.33

e6/l

1.07

322

2221

Other symptoms and signs involving cognitive functions and awareness

371

2492

1.36

7.38

1.4

1.5

4070.07

2399.27

e6/l

0.62

259

1809

Retinal vascular occlusion

115

664

1.75

7.38

1.4

1.5

1164.11

1824.69

e6/l

1.96

478

Dissection of aorta

143

2.71

7.36

1.5

1.3

5110.74

1817.68

e6/l

0.67

106

Malignant neoplasm of small intestine

3.67

7.34

1.3

1.4

11870.10

2185.38

e6/l

—

Zoster [herpes zoster]

146

901

1.63

7.27

1.6

1.5

4720.45

2094.40

e6/l

0.50

104

657

Malignant neoplasm of other and ill-defined digestive organs

6.86

7.22

1.2

1.5

1200.30

1950.35

e6/l

—

Persons with potential health hazards related to communicable diseases

155

963

1.60

7.19

1.5

12859.31

2689.06

e6/l

0.65

696

Noninfectious colitis NAS

522

1.83

7.18

1.3

1.5

3653.48

2220.74

e6/l

0.39

384

Other and unspecified coagulation defects

111

2.91

7.17

1.6

1.3

1211.33

2069.11

e6/l

1.29

Obesity due to excess calories

249

1729

1.44

7.15

1.5

3403.90

3542.12

e6/l

0.03

192

1246

Polycystic kidney disease

3.39

7.14

1.7

1.3

1191.40

2029.43

e6/l

0.70

Benign neoplasm: Sigmoid colon

158

999

1.59

7.14

1.6

1.5

2065.73

2006.54

e6/l

0.04

112

725

Disorders of magnesium metabolism

7.32

7.11

1.4

1.3

475.30

1479.76

e6/l

—

Left ventricular outflow tract obstruction, narrow definition

134

2.72

7.10

1.5

2401.52

1875.43

e6/l

0.32

Umbilical hernia

193

1277

1.52

7.10

1.4

1.5

3278.73

3946.81

e6/l

0.22

135

929

Poisoning by medicine

103

582

1.78

7.08

1.4

9994.60

2584.90

e6/l

0.84

423

Mantle cell lymphoma, including Hilmo

4.30

7.06

1.6

1.3

2588.08

2304.00

e6/l

0.09

Other viral diseases, not elsewhere classified

106

603

1.76

7.06

1.5

3435.90

2301.66

e6/l

0.58

440

Congenital malformations of the urinary system

188

2.42

7.02

1.8

1.4

974.91

2188.48

e6/l

1.99

130

Malignant neoplasm of small intestine, including Hilmo

3.19

7.02

1.6

1.4

9315.08

1991.48

e6/l

0.41

Open wound of ankle and foot

357

2.00

7.02

1.6

1.4

3098.64

1807.44

e6/l

0.39

255

Asthma, hospital admissions , main diagnosis only

511

3502

1.29

7.01

1.5

3072.87

3300.44

e6/l

0.11

380

2522

IgA nephropathy (IgA glomerulonephritis)

3.45

7.01

1.5

1.4

789.26

1807.88

e6/l

1.66

Supplementary factors related to causes of morbidity and mortality classified elsewhere

197

1313

1.51

7.00

1.5

6093.02

2422.52

e6/l

0.43

164

945

Tubulo-interstitial nephritis, not specified as acute or chronic

258

2.19

6.97

1.5

1.4

1935.12

1839.58

e6/l

0.07

191

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

385

1.96

6.97

1.4

13599.76

2745.30

e6/l

0.87

269

Other and unspecified drugs and medicaments

318

2.06

6.94

1.5

1.4

980.40

1850.95

e6/l

2.20

230

Statin medication

377

1565

1.36

6.91

1.5

1.4

2147.61

4119.31

e6/l

1.71

275

1160

Acute myeloid leukaemia and myelodysplastic syndromes

3.51

6.88

1.5

1.4

1570.29

1722.71

e6/l

0.08

N06DA Anticholinesterases

179

2119

0.66

6.86

1.3

1.5

2964.64

2336.50

e6/l

0.25

137

1521

Use of anticholinesterases

179

2119

0.66

6.86

1.3

1.5

2964.64

2336.50

e6/l

0.25

137

1521

Personality disorders, excluding more controls

103

588

1.76

6.84

1.5

1.4

16200.08

2402.71

e6/l

0.85

415

Alcohol-induced chronic pancreatitis

254

2.19

6.83

1.6

1.5

19526.73

1651.60

e6/l

0.48

187

Noninfective enteritis and colitis

280

2002

1.40

6.81

1.4

1.5

2768.21

2776.76

e6/l

0.00

198

1436

Other disorders of veins

255

1786

1.42

6.80

1.5

1889.57

3356.40

e6/l

1.96

174

1295

Malignant neoplasm of corpus uteri

197

2.35

6.80

1.3

1.5

972.81

2075.18

e6/l

0.94

145

Other diseases of urinary system

675

3036

1.25

6.79

1.6

1.5

2953.84

3089.88

e6/l

0.07

479

2242

Malignant neoplasm of cervix uteri, including Hilmo

5.71

6.78

1.3

1.1

703.46

1119.71

e6/l

0.51

Protozoal diseases

110

2.87

6.73

1.7

1.3

2369.08

1638.12

e6/l

0.37

L01XX Other antineoplastic agents

289

2.11

6.72

1.4

2056.50

1670.94

e6/l

0.33

209

Other symptoms and signs involving the digestive system and abdomen

102

585

1.75

6.70

1.5

1804.62

3010.25

e6/l

0.47

420

Other viral diseases, not elsewhere classified

129

784

1.64

6.68

1.4

1.5

3112.33

2520.58

e6/l

0.30

565

Malignant neoplasm of bladder, including Hilmo

101

575

1.76

6.68

1.4

1.5

1056.60

2831.74

e6/l

1.88

432

Asthma, including avohilmo

765

3493

1.23

6.67

1.5

1.4

3044.52

3362.76

e6/l

0.21

563

2528

Intestinal malabsorption

133

2.66

6.66

2.0

1.3

1193.52

1971.27

e6/l

0.81

Exclusions for E4_PCOS_CONSORTIUM

332

1519

1.37

6.66

1.4

2325.29

3649.34

e6/l

1.15

237

1096

Other and unspecified myopathies

428

1.89

6.64

1.5

1.4

19720.84

1814.17

e6/l

0.96

317

malignant neoplasm of male genital organs

213

875

1.49

6.64

1.5

2115.11

3996.81

e6/l

0.82

152

644

Finngen Rheumatological endpoints

586

2632

1.27

6.63

1.5

1.4

2528.29

3872.00

e6/l

1.31

423

1899

Arterial embolism and thrombosis

284

2.10

6.60

1.4

1928.43

1988.27

e6/l

0.03

210

Malignant neoplasm of larynx, including Hilmo

3.51

6.60

1.4

1.5

6192.67

2044.74

e6/l

0.50

Disorders of other endocrine glands

256

1785

1.41

6.59

1.5

5603.38

2707.24

e6/l

0.72

195

1279

Fall involving bed

164

2.49

6.57

1.2

1.3

1466.00

1322.62

e6/l

0.13

119

Gangrene, not elsewhere classified

6.45

6.57

1.8

1.2

1315.29

1819.79

e6/l

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

3.37

6.56

1.3

1678.93

1772.26

e6/l

0.07

Chronic diseases of tonsils and adenoids

239

2142

0.70

6.56

1.5

1.4

3428.96

3619.97

e6/l

0.08

178

1556

Complications of cardiac and vascular prosthetic devices, implants and grafts

101

2.94

6.53

1.7

1.3

2390.13

1513.21

e6/l

0.22

Dependence on enabling machines and devices, not elsewhere classified

6.32

6.50

1.3

1.2

635.25

1602.56

e6/l

—

Psychiatric diseases

662

2657

1.25

6.47

1.5

4000.69

2170.46

e6/l

1.08

493

1904

Other specified/unspecified arthritis

186

1247

1.50

6.47

1.5

1.4

3830.47

3063.05

e6/l

0.28

133

900

Sequelae of other external causes

202

2.30

6.46

1.6

1.4

1443.44

1617.44

e6/l

0.15

140

Presence of other functional implants

429

2277

1.31

6.45

1.5

2030.21

3398.65

e6/l

1.07

315

1637

Malignant neoplasm of endocrine gland

147

2.54

6.43

1.5

1.6

3149.62

2869.75

e6/l

0.06

112

Embolic stroke with flimmer

102

2.89

6.39

1.3

4629.18

2537.54

e6/l

0.30

Use of disulfiram, acamprosate or naltrexone

248

2.15

6.37

1.7

1.5

4620.00

2233.42

e6/l

0.87

175

Soft tissue disorders

658

2720

1.25

6.37

1.5

1.4

2637.04

3054.09

e6/l

0.31

471

1960

Neuroendocrine tumor and carcinoma of small intestine

5.65

6.36

1.4

14489.13

2156.05

e6/l

—

Cystic kidney disease

2.93

6.34

1.7

1.4

1118.68

1762.48

e6/l

0.58

Smoking dependency

302

2.04

6.34

1.3

1.5

8095.60

2376.90

e6/l

0.65

214

Tuberculosis, IBD comorbidity

386

1.91

6.31

1.5

1.4

1880.67

1613.89

e6/l

0.38

277

Cholelithiasis

567

3107

1.26

6.30

1.5

2233.14

2818.89

e6/l

0.60

409

2255

Malignant neoplasm of rectum, including Hilmo

450

1.83

6.28

1.4

1.5

842.38

2972.04

e6/l

2.60

335

Multiple myeloma

3.04

6.26

1.3

1.4

1230.05

2036.15

e6/l

0.80

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

3.04

6.26

1.3

1.4

1230.05

2036.15

e6/l

0.80

Diabetic neuropathy

107

633

1.70

6.25

1.6

1.5

699.32

2329.60

e6/l

5.21

447

Mental and behavioural disorders due to tobacco

304

2.02

6.23

1.3

1.5

8095.60

2382.25

e6/l

0.65

216

Benign neoplasm: Rectum, anus and anal canal

166

1097

1.52

6.23

1.5

1474.81

2227.61

e6/l

1.28

108

793

Abscess of anal and rectal regions

264

2.10

6.21

1.3

1.4

2252.68

1968.96

e6/l

0.22

183

Intracranial and intraspinal abscess and granuloma

5.90

6.20

1.4

1.5

2540.36

2206.14

e6/l

0.14

Migraine, single triptan purchase ok & required. ICD-code if available is included

184

1826

0.68

6.14

1.5

1.4

3717.55

3410.37

e6/l

0.11

137

1309

Triptan medication for migraine, single purchase ok

184

1826

0.68

6.14

1.5

1.4

3717.55

3410.37

e6/l

0.11

137

1309

Malignant neoplasm of corpus uteri, including Hilmo

226

2.18

6.12

1.3

1.4

955.24

1981.65

e6/l

1.06

171

Other disorders of urethra and urinary system

472

2662

1.28

6.11

1.5

2471.90

2979.95

e6/l

0.32

340

1966

Type of accident

181

1222

1.49

6.11

1.5

6445.69

2413.24

e6/l

0.43

149

878

Benign neoplasm: Rectum

148

959

1.55

6.09

1.5

1306.35

2323.35

e6/l

1.94

702

Cystic kidney disease

111

2.74

6.04

1.8

1.4

1207.54

1755.04

e6/l

0.53

Other reaction to severe stress, and adjustment disorders

151

983

1.54

6.04

1.5

1.4

6886.28

2996.63

e6/l

0.62

114

699

Other menopausal disorders

605

0.50

6.02

1.4

3543.05

3943.17

e6/l

0.10

433

Haemolytic anaemias

129

2.60

5.98

1.6

1.3

800.13

1662.77

e6/l

1.69

Adenocarcinoma of pancreas

101

2.82

5.93

1.2

1.4

2906.41

1653.61

e6/l

0.37

Malignant neoplasm of prostate

210

866

1.46

5.90

1.5

2060.70

4022.87

e6/l

0.86

151

636

Carcinoma in situ of skin of scalp and neck

161

2.42

5.88

1.6

1.4

1041.58

1674.31

e6/l

0.89

121

Other metabolic disorders

367

1.89

5.85

1.5

1.4

1482.98

2788.77

e6/l

1.67

269

Other neurological diseases

532

3339

1.26

5.84

1.4

1.5

1626.87

3285.18

e6/l

3.15

409

2418

Epilepsy

217

1527

1.42

5.81

1.4

1.5

4555.79

2779.30

e6/l

0.36

173

1076

Malignant neoplasm of rectum

347

1.92

5.81

1.5

858.98

2281.58

e6/l

1.52

255

Use of rivastigmine

1028

0.51

5.79

1.3

1.5

1364.84

1859.11

e6/l

0.79

757

Degeneration of macula and posterior pole

411

2536

1.29

5.79

1.4

1.5

3361.91

2275.52

e6/l

0.30

299

1845

Abnormal findings in nipple discharge synovial fluid wound secretions

4.97

5.78

1.3

1.2

695.70

2297.75

e6/l

—

Diseases of the eye and adnexa

436

1688

1.30

5.78

1.5

2768.41

3554.28

e6/l

0.64

321

1225

Obesity

331

2412

1.33

5.77

1.6

1.5

3226.30

3570.02

e6/l

0.10

247

1734

Obesity and other hyperalimentation

333

2426

1.33

5.75

1.6

1.5

3221.36

3562.15

e6/l

0.10

248

1745

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

108

651

1.64

5.70

1.6

1.5

8274.54

2229.82

e6/l

1.07

461

Malignant neoplasm of thyroid gland

132

2.52

5.70

1.5

1678.62

3121.60

e6/l

0.77

Multiple myeloma and malignant plasma cell neoplasms

255

2.07

5.63

1.4

946.68

1639.04

e6/l

2.08

185

Methotrexate

505

1.73

5.57

1.4

3163.05

2257.10

e6/l

0.62

363

Extreme obesity with alveolar hypoventilation

134

2.49

5.55

1.4

4778.56

1568.18

e6/l

0.74

Other functional intestinal disorders

312

2181

1.33

5.54

1.5

2484.53

3380.09

e6/l

0.56

231

1586

Familial hypercholesterolemia

128

822

1.57

5.53

1.6

1.5

1507.03

2218.49

e6/l

1.16

109

600

Osteonecrosis due to drugs

3.43

5.49

1.3

3341.33

1706.08

e6/l

0.26

Pleural plaque without asbestos

231

2.12

5.49

1.3

1.5

8039.95

1571.25

e6/l

0.47

168

Gonarthrosis, primary, with knee surgery

286

3031

0.75

5.47

1.5

1818.05

3036.96

e6/l

1.89

210

2197

Pneumonitis due to solids and liquids

464

1.76

5.47

1.5

1.4

1395.62

1949.09

e6/l

0.83

334

Acute upper respiratory infections of multiple and unspecified sites

435

2536

1.27

5.41

1.5

1.4

2710.82

3713.69

e6/l

0.84

337

1802

Other noninfective disorders of lymphatic vessels and lymph nodes

112

2.62

5.40

1.7

1.3

1514.68

1731.97

e6/l

0.16

Renal cell carcinoma of kidney

118

2.58

5.40

1.4

1.5

2125.08

1632.06

e6/l

0.21

Respiratory tuberculosis, confirmed

2.92

5.40

1.3

1.2

2117.63

1347.61

e6/l

0.89

Mental and behavioural disorders due to cannabinoids

5.65

5.38

1.4

1.3

16975.22

2811.57

e6/l

—

Fracture of foot, except ankle

127

821

1.55

5.31

1.5

1.4

2980.33

2451.74

e6/l

0.26

589

Disorders of parathyroid gland

153

1019

1.49

5.27

1.5

5019.93

2731.24

e6/l

0.42

121

733

Sequelae of injuries of neck and trunk

2.86

5.27

1.7

1.5

1959.94

1827.67

e6/l

0.09

Malignant immunoproliferative diseases

3.76

5.26

1.9

1.3

709.00

1848.76

e6/l

1.48

Mental and behavioural disorders due to sedatives or hypnotics

156

2.32

5.26

1.4

1.3

16087.00

1724.73

e6/l

0.57

109

126

2.51

5.25

1.3

1608.68

1450.98

e6/l

0.09

Tuberculosis, wide

411

1.79

5.24

1.5

1.4

1880.67

1587.18

e6/l

0.44

294

Other diseases of stomach and duodenum

283

1.96

5.22

1.6

1.3

1828.78

1619.78

e6/l

0.09

209

Other and unspecified acquired haemolytic anaemias

5.01

5.18

1.9

1.2

630.11

1649.61

e6/l

—

Gastro-oesophageal reflux disease

425

2901

1.27

5.18

1.5

1.4

5030.44

2881.41

e6/l

0.48

323

2115

Corns and callosities

270

1.98

5.17

1.5

1.4

912.35

1722.77

e6/l

2.41

195

Alcohol withdrawal state with delirium

291

1.94

5.17

1.5

20682.83

1627.35

e6/l

0.60

216

Anorexia

4.94

5.15

1.5

1.2

8340.30

1835.33

e6/l

—

Abnormalities of gait and mobility

103

642

1.62

5.09

1.4

1.5

2524.58

1847.83

e6/l

0.25

465

Carbimazole or st.post thyroidectomy, condition for graves disease

109

689

1.59

5.05

1.5

1.4

1732.84

2289.54

e6/l

0.85

503

Disorders of skin appendages

240

1765

1.36

5.05

1.5

3652.21

3122.93

e6/l

0.14

182

1263

Persons encountering health services in other circumstances

226

1641

1.37

5.03

1.5

2620.33

3006.91

e6/l

0.15

172

1196

Transient ischemic attack

414

2652

1.27

5.03

1.4

1.5

1618.91

3001.91

e6/l

1.99

326

1913

Other systemic involvement of connective tissue (FG)

174

1199

1.44

5.02

1.4

2237.86

2566.57

e6/l

0.18

108

852

Alcohol abuse, main dg, excluding more controls

536

1.67

5.02

1.3

1.5

3185.81

2275.92

e6/l

0.43

381

Viral and other specified intestinal infections

515

1.67

5.01

1.4

1993.89

2751.17

e6/l

0.75

375

Intestinal adhesions without obstruction

373

1.81

5.00

1.4

4038.09

1752.17

e6/l

0.46

266

Hypercalcemia

186

2.18

4.99

1.6

1.3

1281.83

1621.89

e6/l

0.35

131

Other systemic involvement of connective tissue

178

1250

1.43

4.99

1.4

1.5

2187.96

2595.27

e6/l

0.24

112

901

Thiazolidinediones

607

1.63

4.98

1.8

1.5

1216.19

1711.27

e6/l

0.90

446

Diseases of pulp and periapical tissues, including avohilmo

696

2999

1.20

4.91

1.5

2334.16

2936.45

e6/l

0.67

507

2169

Adenocarcinoma and papilloma adenocarcinoma of rectum

339

1.84

4.90

1.5

857.73

2118.64

e6/l

1.26

247

Respiratory tuberculosis, bacteriologically and histologically confirmed

2.75

4.88

1.3

1.2

2117.63

1329.59

e6/l

0.95

Drug-induced osteoporosis

4.33

4.87

1.8

1.3

3963.91

1599.54

e6/l

0.41

Malignant neoplasm of other and unspecified parts of tongue

4.31

4.86

1.7

1.2

520.30

1992.77

e6/l

—

Myeloid leukaemia

113

2.52

4.82

1.6

1.4

2072.05

1486.58

e6/l

0.50

Viral infections characterized by skin and mucous membrane lesions

511

3560

1.23

4.80

1.5

3256.09

3342.36

e6/l

0.03

361

2584

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

356

1.81

4.80

1.5

842.91

2409.34

e6/l

1.72

264

Carcinoma in situ of skin of other and unspecified parts of face

529

1.66

4.79

1.6

1.4

2186.77

1857.90

e6/l

0.14

391

Hyperparathyroidism

135

897

1.50

4.77

1.5

2979.20

2162.48

e6/l

0.29

104

642

Dental pulpitis, including avohilmo

300

2531

0.77

4.77

1.5

4500.83

3821.07

e6/l

0.19

219

1827

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

3.43

4.75

1.4

1.3

2722.30

2967.68

e6/l

—

Obesity, other/unspecified

158

1096

1.45

4.74

1.7

1.5

4544.37

2647.75

e6/l

0.34

112

789

Personal history of other diseases and conditions

189

2.12

4.72

1.6

1.4

1878.15

2967.90

e6/l

0.65

128

Other necrotizing vasculopathies

337

1.83

4.70

1.6

1.5

1376.17

1526.56

e6/l

0.19

244

Other coagulation defects

245

1.97

4.69

1.5

1.4

7053.94

1911.20

e6/l

0.42

172

Exposure to other and unspecified inanimate mechanical forces

211

2.05

4.67

1.7

1.5

2116.64

1916.43

e6/l

0.11

152

Other and unspecified nonorganic psychotic disorders

494

1.67

4.64

1.5

1.4

3547.49

2801.36

e6/l

0.30

353

Portal vein thrombosis

3.55

4.64

1.5

1.3

3451.25

1920.86

e6/l

—

Glaucoma secondary to other eye disorders

179

2.15

4.62

1.3

1541.64

1537.76

e6/l

0.00

127

Hernia of abdominal wall

310

2405

1.29

4.59

1.4

1.5

3132.62

3379.99

e6/l

0.10

220

1746

Spondyloarthritis

116

762

1.53

4.58

1.5

12818.03

2384.16

e6/l

0.66

555

Diseases of the musculoskeletal system and connective tissue

315

1210

1.31

4.58

1.5

1.4

2455.68

3530.09

e6/l

0.67

225

861

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

157

1762

0.70

4.56

1.4

1.5

4359.94

2868.65

e6/l

0.28

123

1278

Amputation of thigh

167

2.19

4.56

1.7

1.4

566.59

1311.14

e6/l

2.80

123

Actinic keratosis

332

2407

1.28

4.54

1.5

3850.31

2183.15

e6/l

0.38

223

1756

Other chondrocalcinosis

3.23

4.53

1.2

1.3

995.25

1716.68

e6/l

0.60

Other and unspecified injuries of head

263

1.92

4.49

1.5

1.4

20266.60

1766.50

e6/l

0.47

187

Focal epilepsy

138

944

1.47

4.48

1.4

1.5

2427.09

2321.90

e6/l

0.09

114

682

Dementia in Alzheimer disease

1162

0.63

4.48

1.3

1.5

1433.90

1849.22

e6/l

0.58

850

Unspecified jaundice

229

1.99

4.46

1.5

1.3

1602.08

1648.04

e6/l

0.02

163

Carcinoma in situ of skin

463

1.68

4.45

1.4

1295.91

2069.34

e6/l

1.38

346

Schizophrenia or delusion, excluding more controls

144

986

1.45

4.41

1.5

5687.08

2256.93

e6/l

1.05

101

703

Spondylopathies

545

2684

1.22

4.40

1.5

4510.58

2782.94

e6/l

0.45

400

1933

Bicuspidal aortic valve syndrome

106

2.48

4.39

1.6

1.5

2657.90

1818.74

e6/l

0.44

Essential (haemorrhagic) thrombocythaemia

106

2.48

4.39

1.3

1.6

1210.30

1712.00

e6/l

0.59

Idiopathic pulmonary fibrosis

473

1.67

4.37

1.6

1.4

6477.37

1587.84

e6/l

0.56

341

Malignant neoplasm of prostate, including Hilmo

204

882

1.38

4.37

1.5

2137.67

4007.01

e6/l

0.82

147

651

Tuberculosis

353

1.77

4.36

1.4

1868.19

1613.95

e6/l

0.35

256

Right hemicolectomy

302

1.84

4.36

1.3

1.4

908.55

1648.25

e6/l

1.28

220

Respiratory tuberculosis, confirmed and not-confirmed

302

1.84

4.36

1.4

1859.46

1760.33

e6/l

0.11

219

Respiratory tuberculosis

302

1.84

4.36

1.4

1859.46

1760.33

e6/l

0.11

219

Other diseases of biliary tract

398

1.72

4.33

1.4

4376.77

2222.68

e6/l

0.44

288

Procreative management

129

728

1.48

4.32

1.4

2685.80

3464.82

e6/l

0.39

534

Vitamin deficiency

171

2.13

4.30

1.3

1639.26

1579.68

e6/l

0.04

119

Vitamin deficiency, wide

171

2.13

4.30

1.3

1639.26

1579.68

e6/l

0.04

119

Viral haemorrhagic fevers, not elsewhere classified/unspecified

638

1.56

4.29

1.4

1.5

1271.00

2303.01

e6/l

2.04

474

Myeloproliferative diseases

392

1.72

4.29

1.3

1.4

1913.15

1770.74

e6/l

0.12

285

Skin changes due to chronic exposure to nonionizing radiation

335

2441

1.27

4.28

1.5

3823.34

2170.88

e6/l

0.38

226

1782

Caries of enamel

305

2807

0.78

4.28

1.6

1.4

4854.98

3587.33

e6/l

0.23

201

2037

Oesophageal obstruction

165

2.15

4.27

1.4

1.3

1539.36

1692.21

e6/l

0.13

111

Motorcycle rider injured in noncollision transport accidents

3.06

4.25

1.9

1.4

7027.58

2366.37

e6/l

0.73

Marginal zone B-cell lymphoma, including Hilmo

3.32

4.21

1.5

1.1

1167.38

2490.83

e6/l

—

Malignant neoplasm of thyroid gland, including Hilmo

159

2.15

4.21

1.5

1.6

1678.62

2693.80

e6/l

0.59

120

Other diseases of anus and rectum

213

1587

1.34

4.19

1.5

1795.11

2845.65

e6/l

0.84

168

1147

Dermatophytosis

619

1.56

4.18

1.5

1.4

1799.96

1972.10

e6/l

0.11

449

Other and unspecified effects of external causes

127

868

1.47

4.18

1.5

1.4

2750.38

2423.98

e6/l

0.14

627

Primary gonarthrosis, bilateral

253

2813

0.77

4.17

1.5

2103.80

3022.79

e6/l

0.96

193

2034

Other spirochaetal diseases

1314

0.64

4.16

1.5

3540.24

2846.19

e6/l

0.16

952

346

2526

1.26

4.15

1.5

3758.67

2163.12

e6/l

0.37

232

1840

Follow-up examination after treatment for conditions other than malignant neoplasms

252

1267

1.32

4.14

1.5

1.4

5595.12

2396.71

e6/l

0.41

183

860

Assault

314

1.79

4.13

1.6

1.4

6942.53

2463.81

e6/l

1.14

219

Hepatocellular carcinoma, including Hilmo

116

2.36

4.11

2.1

1.5

1571.91

1542.50

e6/l

0.01

Injuries to the elbow and forearm

395

2808

1.24

4.09

1.4

1.5

7522.20

2658.00

e6/l

0.96

291

2011

Diseases of spleen

2.91

4.09

1.6

1.4

1290.50

1699.23

e6/l

0.38

Injuries to unspecified part of trunk, limb or body region

405

1.69

4.08

1.8

1.4

1585.35

1734.87

e6/l

0.10

297

Unspecific neurodegenerative disorder

254

2250

0.77

4.08

1.4

1.5

3505.87

2205.12

e6/l

0.65

187

1626

Lyme disease

1304

0.64

4.03

1.5

3540.24

2842.80

e6/l

0.16

944

Spirochaetal infections, other/unspecified

1315

0.64

4.02

1.5

3492.13

2842.14

e6/l

0.15

952

Other spirochaetal diseases

1325

0.65

3.99

1.5

3492.13

2834.87

e6/l

0.15

960

Colectomy operation

127

878

1.45

3.98

1.3

1.5

1794.83

2115.55

e6/l

0.32

642

Myocardial infarction, unclassifiable

218

1468

1.33

3.98

1.4

1.5

3241.36

2110.69

e6/l

0.27

163

1057

Neovascular glaucoma

177

2.06

3.96

1.3

1.4

1639.38

1454.68

e6/l

0.12

126

Nerve, nerve root and plexus disorders

677

3528

1.18

3.91

1.5

2811.86

3331.92

e6/l

0.32

514

2537

Other surgical follow-up care

2.66

3.90

1.3

1.2

17170.42

1858.89

e6/l

0.47

Benign neoplasm: Duodenum

113

2.34

3.88

1.5

1.3

1903.95

1732.95

e6/l

0.11

Other specified disorders of kidney and ureter

113

2.33

3.87

1.2

1.3

2703.00

1630.03

e6/l

0.19

Abdominal aortic aneurysm (AAA)

102

674

1.51

3.86

1.4

1.5

1685.72

2153.23

e6/l

0.30

496

Benign neoplasm of other and ill-defined parts of digestive system

123

851

1.45

3.85

1.6

1.5

1624.48

2095.03

e6/l

0.87

615

Use of memantine

156

1773

0.73

3.84

1.4

1.5

3563.62

2305.24

e6/l

0.39

120

1275

Use of other anti-dementia drugs

156

1773

0.73

3.84

1.4

1.5

3563.62

2305.24

e6/l

0.39

120

1275

Other inflammatory liver diseases

235

1.89

3.83

2.0

1.3

6039.94

1803.80

e6/l

0.79

166

Lichen simplex chronicus and prurigo

264

1.83

3.82

1.6

1.4

2549.67

1882.22

e6/l

0.31

192

Arterial embolism and thrombosis of lower extremity artery

166

2.07

3.82

1.5

1.4

2204.08

1562.23

e6/l

0.20

122

Emotionally unstable personality disorder

186

2.00

3.82

1.9

1.4

4509.69

3258.12

e6/l

0.28

130

Retinal detachments and breaks

261

2035

1.29

3.81

1.4

1.5

4960.80

2293.20

e6/l

0.34

187

1468

Other diseases of oesophagus

460

1.62

3.80

1.9

1.4

5981.48

1640.56

e6/l

0.91

336

Personality disorders

103

690

1.50

3.78

1.5

1.4

16200.08

2764.69

e6/l

0.82

493

Acute sinusitis

243

1738

1.30

3.75

1.5

3177.57

4187.96

e6/l

0.45

184

1229

Symptoms and signs involving the skin and subcutaneous tissue

420

3385

1.22

3.73

1.5

4020.30

2989.06

e6/l

0.30

322

2440

Malignant neoplasm of liver and intrahepatic bile ducts

115

2.29

3.73

1.9

1.5

707.29

1426.81

e6/l

1.55

Alcohol abuse, main dg

582

1.54

3.68

1.3

1.5

3185.81

2404.14

e6/l

0.35

415

Other skin changes

131

927

1.42

3.65

1.5

6903.08

2129.14

e6/l

0.55

105

670

Urticaria and erythema

172

1273

1.35

3.64

1.5

2229.92

2801.82

e6/l

0.42

127

920

Specific personality disorders

585

1.53

3.59

1.7

1.4

4306.81

2722.07

e6/l

0.58

424

Inflammatory diseases of the central nervous system

299

1.75

3.59

1.3

1.4

2416.95

1873.35

e6/l

0.28

216

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Leukocytes [#/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS